Summary
Other Scenarios:
- JNJ - PFE
- JNJ - NVS
- PFE - WPI
- NVS - WPI
| Buyer: | Johnson & Johnson (JNJ) | Last Price: | 64.42 | Market Cap.: | 188.43B |
|---|---|---|---|---|---|
| Target: | Watson Pharmaceuticals, Inc. (WPI) | Last Price: | 25.60 | Market Cap.: | 2.62B |
Lines of Business Summary:
- Johnson & Johnson (JNJ) competes in 2 industries and 494 product/service groups
- Watson Pharmaceuticals, Inc. (WPI) competes in 1 industry and 246 product/service groups
- A combined entity will have 3% Product/Service Group overlap
- Johnson & Johnson (JNJ) has 15 and Watson Pharmaceuticals, Inc. (WPI) has 1 suppliers that rely on a material % of their business. They share 0 in common.
- Johnson & Johnson (JNJ) has 0 and Watson Pharmaceuticals, Inc. (WPI) has 4 customers that derive significant revenue from each. They share 0 in common.
Product Summary:
Overlap & Complementary Sectors
| Sector | Buyer | Target | # of Focused Companies |
|---|---|---|---|
*Healthcare |
|
|
866 |
Biopharmaceuticals |
|
|
322 |
|
Healthcare Services |
|
158 | |
|
Medical Devices |
|
|
245 |
|
Nutritional Health |
|
|
23 |
|
Outsourced Services |
|
|
69 |
|
Manufacturing |
|
1,173 | |
|
Consumer Manufacturing |
|
345 |
- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.
- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.
- Sector Participation. Denotes that the company develops products in this line of business.
Sample Products in Similar Lines of Business |
Sample Products in Complementary Lines of Business |
||
Buyer (Total: 978)
|
Target (Total: 229)
|
Buyer
|
Target
|
Business Relationship Summary:
Top Key Suppliers |
Top Key Customers |
||
Buyer (Total: 77)
|
Target (Total: 3)
|
Buyer (Total: 15)
|
Target (Total: 5)
|
Key Financial Summary:
Key Metrics
| Buyer | Target | |
|---|---|---|
| Number of Employees | 116,200 | 3,844 |
| Revenue Per Employee | 463,657.8 | 533,081.3 |
| Total Revenue | 13,363.0 | 510.4 |
| Total Expenses | 9,760.0 | 540.8 |
Other Revenue
|
0.0 | 0.0 |
|
Cost of Revenue
|
3,788.0 | 330.9 |
|
SG&A Expense
|
4,351.0 | 70.8 |
|
Research & Development
|
1,828.0 | 31.1 |
|
Other Operating Expense
|
-98.0 | 0.0 |
|
Operating Income
|
3,603.0 | -30.5 |
|
Unusual Income
|
87.0 | 67.0 |
|
LT Debt to Capital
|
4.64 | 21.22 |
|
Fwd P/E
|
17.41 | 20.81 |
|
Fwd P/Rev
|
3.55 | 1.40 |
| Book Value | 40,742.0 | 2,131.3 |
|
Curr Portion of LTD/Cap Lease
|
0.0 | 10.4 |
Key Ratios
| Buyer | Target | |
|---|---|---|
|
Gross Margin %
|
71.99 | 42.76 |
|
Operating Margin %
|
28.1 | 5.6 |
|
Quick Ratio
|
1.88 | 2.93 |
|
Current Ratio
|
2.59 | 4.12 |
|
Coverage Ratio
|
0 | 0.09 |
| Total Assets | 60,990.0 | 3,190.9 |
| Return on Equity % | 26.83 | 3.23 |
| Return on Assets % | 17.93 | 2.16 |
|
Cash+ ST Inv. Per Share
|
4.95 | 7.57 |
| Total Debt | 2,635.0 | 584.4 |
| Total Debt to Equity % | 6.47 | 27.42 |
| Total Debt to Tangible Equity % | 9.59 | 55.62 |
|
Debt to Asset %
|
4.32 | 18.31 |
Individual Company Summary
Focused
Buyer
Focused ():
*Healthcare > Biopharmaceuticals
Focused ():
*Healthcare > Medical Devices
Target
Focused ():
*Healthcare > Biopharmaceuticals
Business Description
Buyer
Johnson & Johnson is engaged in the manufacture and sale of a range of products in the healthcare field. Johnson & Johnson has more than 230 operating companies. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Sales of the Company's two largest products, RISPERDAL and PROCRIT(R)/EPREX, accounted for approximately 6% and 7% of Johnson & Johnson's total revenues, respectively, during the fiscal year ended January 1, 2006 (fiscal 2005).
Target
Watson Pharmaceuticals, Inc. (Watson) is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent (generic) pharmaceutical products. Watson operates manufacturing, distribution, research and development, and administrative facilities primarily in the United States. As of December 31, 2005, the Company marketed more than 125 generic pharmaceutical products and more than 20 brand pharmaceutical products. The Company operates in two segments: generic and brand.
Product Summary
| Sector | Buyer | Target |
|---|---|---|
|
*Healthcare |
|
|
Biopharmaceuticals |
|
|
|
Allergies
The Allergies Subsector includes therapeutics that treat exaggerated immune reaction induced by exposure to a foreign substance.
|
|
|
|
Cardiovascular System
The Cardiovascular System Subsector includes therapeutics that treat disorders affecting the heart and blood vessels.
|
|
|
|
Dermatology
The Dermatology Subsector includes therapeutics that treat disorders affecting the skin.
|
|
|
|
Digestive System
The Digestive System Subsector includes therapeutics that treat disorders affecting the digestive system.
|
|
|
|
Endocrinology/Metabolism
The Endocrinology/Metabolism Subsector includes therapeutics that treat metabolic disorders and conditions resulting from the dysfunction of hormone secreting glands.
|
|
|
|
Hematology
The Hematology Subsector includes therapeutics that treat blood-based diseases and disorders.
|
|
|
|
Immunology
The Immunology Subsector includes therapeutics that treat disorders affecting the immune system.
|
|
|
|
Infectious Diseases
The Infectious Diseases Subsector includes therapeutics that treat diseases caused by the invasion and reproduction of microorganisms in the body.
|
|
|
|
Musculoskeletal System
The Musculoskeletal System Subsector includes therapeutics that treat disorders of the bones, joints, ligaments, tendons, and soft tissue involved with them.
|
|
|
|
Neurology
The Neurology Subsector includes therapeutics that treat disorders of the central nervous system, including the brain, spinal cord, and nerves.
|
|
|
|
Obstetrics/Gynecology
The Obstetrics/Gynecology Subsector includes therapeutics that treat female genital disorders, pregnancy, and childbirth.
|
|
|
|
Oncology
The Oncology Subsector includes therapeutics that treat and manage various types of cancer and related complications.
|
|
|
|
Ophthalmology
The Ophthalmology Subsector includes therapeutics that treat eye disorders, infections, inflammations and irritations.
|
|
|
|
Pain Management
The Pain Management Subsector includes therapeutics that treat and management pain.
|
|
|
|
Respiratory System
The Respiratory System Subsector includes therapeutics that treat disorders affecting both the upper and lower respiratory tract, including the nose, throat, larynx, trachea, bronchi, and lungs.
|
|
|
|
Surgery
The Surgery Subsector includes therapeutics that treat complications associated with surgical procedures.
|
|
|
|
Toxicology
The Toxicology Subsector includes therapeutics that treat harmful effects from exposure to toxic substances; narcotics, nicotine and alcohol withdrawal therapeutics are also included in this sector.
|
|
|
|
Transplantation
The Transplantation Subsectors includes therapeutics that treat rejection and infection associated with tissue transplantation into the human body.
|
|
|
|
Urology
The Urology Subsector includes therapeutics that treat diseases of the kidney, urinary tract, bladder, and the male reproductive system.
|
|
|
|
Weight Management
The Weight Management Subsectors includes herapeutics that treat and manage weight disorders.
|
|
|
|
Wound Management
The Wound Management Subsector includes therapeutics that treat cuts, abrasions, and burns from trauma or diseases.
|
|
|
|
Healthcare Services |
|
|
|
Support Services
The Support Services Subsector comprises of companies that provide non-medical services for managing, enhancing, facilitating, and enabling the healthcare delivery process.
|
|
|
|
Medical Devices |
|
|
|
Cardiology
The Cardiology Subsector includes medical devices that diagnose, monitor, and treat diseases affecting the heart and proximal blood vessels. Common devices include vital sign monitors, cardiac defibrillators, pacemakers, and other surgical equipment.
|
|
|
|
Clinical Diagnostics
The Clinical Diagnostics Subsector includes medical devices that analyze human body specimens within a medical setting. These devices, including equipment, biological and chemical reagents are primarily used for the diagnosis of diseases.
|
|
|
|
Dental
The Dental Subsector includes medical devices that diagnose and treat dental disorders, as well as restore proper function and appearance of teeth and gums.
|
|
|
|
Drug Delivery
The Drug Delivery Subsector includes medical devices that facilitate the delivery of medications through different anatomical entryways, including blood vessels, skin, the mouth, and the lungs. Common devices in this sector include vascular access catheters, needles, implants, and inhalers.
|
|
|
|
Gastroenterology
The Gastroenterology Subsector includes medical devices that diagnosis and treat conditions affecting the stomach and intestinal tract.
|
|
|
|
General Surgery
The General Surgery Subsector includes medical devices that perform general, non-specialty surgeries; these devices are often general in scope and are used in procedures involving various parts of the body.
|
|
|
|
Medical Supplies
The Medical Supplies Subsector includes basic and consumable products that are widely used in healthcare settings.
|
|
|
|
Neurology
The Neurology Subsector includes medical devices that diagnose, monitor and treat neurological disorders.
|
|
|
|
Obstetrics/Gynecology
The Obstetrics/Gynecology Subsector includes medical devices that diagnose and treat female reproductive diseases; devices used to care for women during pregnancy, childbirth, and the post-partum period are also included in this sector.
|
|
|
|
Oncology
The Oncology Subsector includes medical devices that detect and treat cancers.
|
|
|
|
Ophthalmology
The Ophthalmology Subsector includes medical devices that diagnose and treat eye disorders.
|
|
|
|
Orthopedics
The Orthopedics Subsector includes medical devices that diagnose and treat musculoskeletal diseases involving muscles, bones and joints.
|
|
|
|
Plastic/Reconstructive Surgery
The Plastic/Reconstructive Surgery Subsector includes medical devices that treat and modify a patient's external appearance.
|
|
|
|
Radiology
The Radiology Subsector includes medical devices that generate images of internal physiology.
|
|
|
|
Transfusion Medicine
The Transfusion Medicine Subsector includes medical devices and accessories that prepare or implement blood transfusion.
|
|
|
|
Urology
The Urology Subsector includes medical that diagnose and treat urinary tract and male reproductive disorders.
|
|
|
|
Vascular
The Vascular Subsector includes medical devices that diagnose and treat of conditions affecting the blood vessels.
|
|
|
|
Nutritional Health |
|
|
|
Dietary/Naturopathic Supplements
The Dietary/Naturopathic Subsector includes nutritional biochemicals and nutrients derived from natural sources that are intended to support health.
|
|
|
|
Nutraceuticals
The Nutraceuticals Subsector includes products in a food, or part of a food, that may provide medical or health benefits.
|
|
|
|
Outsourced Services |
|
|
|
Analytical Services
The Analytical Services Subsector includes outsourced services that utilize analytical instruments to analyze biological and chemical samples.
Target Products:
|
|
|
|
Development/Manufacturing Services
The Development/Manufacturing Services Subsector includes companies that provide research, development, manufacturing, sales and marketing to biopharmaceutical and medical device companies.
|
|
|
|
Drug Delivery Technology
The Drug Delivery Technology Subsector includes companies that develop novel delivery methods for therapeutics.
|
|
|
|
Drug Discovery Services
The Drug Discovery Services Subsector includes companies that provide biopharmaceutical companies with novel biological targets and drug leads.
|
|
|
|
Manufacturing |
|
|
|
Consumer Manufacturing |
|
|
|
Food, Beverage and Agriculture
Includes agricultural inputs like livestock and crops, as well as processed food and beverage products. Tobacco growers and cigarette manufacturers are also included.
|
|
|
|
Personal Care and Cleaning Products
Companies engaged in the manufacturing of personal care products, such as cosmetics, fragrances, skin lotion, shampoo and other toiletries; and household cleaning products, such as window/surface cleaner, table polish.
|
|
- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.
- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.
- Sector Participation. Denotes that the company develops products in this line of business.
Product Details
| Sector | Buyer | Target |
|---|---|---|
|
*Healthcare |
|
|
|
Biopharmaceuticals |
|
|
Allergies |
|
|
Dermatology |
|
|
|
Antihistamines
Products that inhibit inflammation by blocking the action of histamines on tissues.
Target Products:
|
|
|
|
Ophthalmology |
|
|
|
Antihistamines
Therapeutics that inhibit inflammation by blocking the action of histamines on tissues.
Buyer Products:
Target Products:
|
|
|
|
Upper Respiratory |
|
|
|
Antihistamines
Therapeutics that inhibit the inflammation by blocking the action of histamines on tissues.
Buyer Products:
Target Products:
|
|
|
|
Antihistamines/Analgesics/Antipyretics
Therapeutics that treat allergic reactions by suppressing inflammation, relieving pain, and reducing fever.
Buyer Products:
|
|
|
|
Antihistamines/Decongestants
Therapeutics that block the inflammatory action of histamines and relieve or prevent coughs.
Target Products:
|
|
|
|
Antihistamines/Decongestants/Analgesics/Antipyretics
Therapeutics that treat allergic reactions by suppressing inflammation, reducing mucous build up, relieving pain, and reducing fever.
Buyer Products:
|
|
|
|
Antihistamines/Decongestants/Antitussives
Therapeutics that treat allergic reactions by suppressing inflammation, reducing mucous build up, and relieving or preventing coughs.
Target Products:
|
|
|
|
Antihistamines/Decongestants/Antitussives/Analgesics/Antipyretics
Therapeutics that treat allergic reactions by suppressing inflammation, reducing mucous build up, relieving or preventing coughs, relieving pain, and reducing fever.
Buyer Products:
|
|
|
|
Cardiovascular System |
|
|
|
Heart Disorders |
|
|
|
Acute Coronary Syndrome (ACS) |
|
|
|
Anticoagulating Agents |
|
|
|
Platelet Aggregation Inhibitors |
|
|
|
Glycoprotein IIb/IIIa Receptor Blocking Agents
Therapeutics that treat acute coronary syndrome by blocking the receptor that allows platelets to clump together.
Buyer Products:
|
|
|
|
Angina |
|
|
|
Anticoagulating Agents |
|
|
|
Platelet Aggregation Inhibitors |
|
|
|
Glycoprotein IIb/IIIa Receptor Blocking Agents
Therapeutics that treat angina by blocking the receptor that allows platelets to clump together.
Buyer Products:
|
|
|
|
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat chest pains by inhibiting stimulation of beta adrenergic receptors of the heart muscle.
Target Products:
|
|
|
|
Calcium Channel Blocking Agents
Therapeutics that treat chest pains by preventing the entry of calcium into heart muscle cells.
Buyer Products:
Target Products:
|
|
|
|
Arrhythmia |
|
|
|
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat abnormal rhythm of the heart beat by inhibiting the stimulation of beta adrenergic receptors of the heart muscle.
Target Products:
|
|
|
|
Calcium Channel Blocking Agents
Therapeutics that treat abnormal rhythm of the heart by preventing the entry of calcium into heart muscle cells.
Target Products:
|
|
|
|
Potassium Channel Blocking Agents
Therapeutics that treat abnormal rhythm of the heart by preventing the entry of potassium into heart muscle cells.
Target Products:
|
|
|
|
Sodium Channel Blocking Agents
Therapeutics that treat abnormal rhythm of the heart by preventing the entry of sodium into heart muscle cells.
Target Products:
|
|
|
|
Heart Failure (HF) |
|
|
|
Adjunctive Treatments |
|
|
|
Angiotensin Converting Enzyme Inhibitors (ACE Inhibitors)
Therapeutics that assist in the primary treatment of the ineffective pumping of the heart by inhibiting the renin-angiotensin system.
Target Products:
|
|
|
|
Angiotensin Converting Enzyme Inhibitors (ACE Inhibitors)
Therapeutics that treat the ineffective pumping of the heart by inhibiting the renin-angiotensin system.
Target Products:
|
|
|
|
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat the ineffective pumping of the heart by blocking beta adrenergic receptors of the heart muscle.
Target Products:
|
|
|
|
Complications |
|
|
|
Edema |
|
|
|
Potassium Sparing Diuretic Agents/Thiazide Diuretic Agents
Therapeutics that treat the accumulation of fluid by increasing the excretion of water and sodium, but not potassium in urine.
Target Products:
|
|
|
|
Sulfonamide Diuretic Agents
Therapeutics that treat the accumulation of fluid by increasing the excretion of sodium, potassium ions, and water in urine.
Target Products:
|
|
|
|
Thiazide Diuretic Agents
Therapeutics that treat the accumulation of fluid by increasing the excretion of sodium, potassium ions, and water in urine.
Target Products:
|
|
|
|
Recombinant B-Type Natriuretic Peptides (BNP)
Therapeutics that treat the ineffective pumping of the heart by increasing the excretion of sodium and water in urine.
Buyer Products:
|
|
|
|
Myocardial Infarction (MI) |
|
|
|
Angiotensin Converting Enzyme Inhibitors (ACE Inhibitors)
Therapeutics that treat irreversible damage to the heart muscle by inhibiting the renin-angiotensin system.
Target Products:
|
|
|
|
Anticoagulating Agents |
|
|
|
Platelet Aggregation Inhibitors |
|
|
|
Glycoprotein IIb/IIIa Receptor Blocking Agents
Therapeutics that treat myocardial infarction by preventing various adhesive factors from attaching to the specific receptor and causing platelet aggregation.
Buyer Products:
|
|
|
|
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat irreversible damage to the heart muscle by blocking the beta adrenergic receptors of the heart muscle.
Target Products:
|
|
|
|
HMG CoA Reductase Inhibitors (Statins)
Therapeutics that treat irreversible damage to the heart muscle by preventing the synthesis of cholesterol.
Target Products:
|
|
|
|
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of heart and circulatory system disorders in early stages of clinical research where human subject is involved.
Buyer Products:
|
|
|
|
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of heart and circulatory system disorders in very early stages of research where no human subject is involved.
Buyer Products:
|
|
|
|
Vascular Disorders |
|
|
|
Atherosclerosis |
|
|
|
HMG CoA Reductase Inhibitors (Statins)
Therapeutics that treat the narrowing or hardening of the arteries by preventing the synthesis of cholesterol.
Target Products:
|
|
|
|
Hypertension |
|
|
|
Alpha Adrenergic Receptor Agonists
Therapeutics that treat high blood pressure by stimulating the alpha adrenergic receptors of the heart muscle.
Target Products:
|
|
|
|
Alpha Adrenergic Receptor Blocking Agents (Alpha Blockers)
Therapeutics that treat high blood pressure by blocking alpha adrenergic receptors of the heart muscle.
Target Products:
|
|
|
|
Alpha Adrenergic Receptor Blocking Agents (Alpha Blockers)/Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat high blood pressure by blocking alpha and beta adrenergic receptors of the heart muscle.
Target Products:
|
|
|
|
Angiotensin Converting Enzyme Inhibitors (ACE Inhibitors)
Therapeutics that treat high blood pressure by inhibiting the renin-angiotensin system.
Target Products:
|
|
|
|
Angiotensin Converting Enzyme Inhibitors (ACE Inhibitors)/Thiazide Diuretic Agents
Therapeutics that treat high blood pressure by inhibiting the renin-angiotensin system and increasing the excretion of sodium ions, potassium ions, and water through urine.
Target Products:
|
|
|
|
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat high blood pressure by blocking the beta adrenergic receptors of the heart muscle.
Target Products:
|
|
|
|
Beta Receptor Blocking Agents (Beta Blockers)/Thiazide Diuretic Agents
Therapeutics that treat high blood pressure by blocking the beta adrenergic receptors of the heart muscle and increasing the excretion of sodium ions, potassium ions, and water through urine.
Target Products:
|
|
|
|
Calcium Channel Blocking Agents
Therapeutics that treat high blood pressure by blocking the beta adrenergic receptors of the heart muscle and increasing the excretion of sodium ions, potassium ions, and water through urine.
Target Products:
|
|
|
|
Potassium Sparing Diuretic Agents/Thiazide Diuretic Agents
Therapeutics that treat high blood pressure by increasing the excretion of water and sodium, but not potassium in urine.
Target Products:
|
|
|
|
Sulfonamide Diuretic Agents
Therapeutics that treat high blood pressure by increasing the excretion of sodium, potassium ions, and water in urine.
Target Products:
|
|
|
|
Thiazide Diuretic Agents
Therapeutics that treat high blood pressure by increasing the excretion of sodium, potassium ions, and water in urine.
Target Products:
|
|
|
|
Vasodilatory Agents
Therapeutics that treat high blood pressure by causing relaxation of the blood vessels.
Target Products:
|
|
|
|
Stroke |
|
|
|
Anticoagulating Agents (Anticoagulants) |
|
|
|
Platelet Aggregation Inhibitors |
|
|
|
Glycoprotein IIb/IIIa Receptor Blocking Agents
Therapeutics that prevent or treat damage to nerve cells of the brain by preventing various adhesive factors from attaching to the specific receptor and causing platelet aggregation.
Buyer Products:
|
|
|
|
Tremors |
|
|
|
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that prevent or treat involuntary trembling by blocking the beta adrenergic receptors in muscle tissue.
Target Products:
|
|
|
|
Dermatology |
|
|
|
Acne |
|
|
|
Vulgaris |
|
|
|
Estrogens/Progestins
Therapeutics that treat acne by providing estrogen and progestin.
Target Products:
|
|
|
|
Keratolytic Agents
Therapeutics that soften, separate, and cause the shedding of skin.
Target Products:
|
|
|
|
Retinoids/Vitamin A Analogs
Therapeutics that treat acne by helping in cell differentiation as well as prevent cell proliferation.
Buyer Products:
|
|
|
|
Aging Disorders |
|
|
|
Photoaging |
|
|
|
Retinoids/Vitamin A Analogs
Therapeutics that treat the effects of aging and sun exposure by promoting the growth and differentiation of epithelial cells.
Buyer Products:
|
|
|
|
Hair Disorders |
|
|
|
Alopecia (Hair Loss) |
|
|
|
5 Alpha Reductase Inhibitors
Therapeutics that treat hair loss by blocking the action of an enzyme that converts testosterone to a testosterone derivative.
Target Products:
|
|
|
|
Lesion/Scaling Disorders |
|
|
|
Dermatitis |
|
|
|
Atopic (Eczema) |
|
|
|
Steroidal Anti-Inflammatory Drugs (SAID)
Therapeutics that treat atopic dermatoses by inhibiting the accumulation of inflammatory cells like leucocytes and macrophages at the inflammation site.
Target Products:
|
|
|
|
Seborrheic (Dandruff) |
|
|
|
Anti-Mitotic Agents
Therapeutics that block the mitotic division of cells.
Target Products:
|
|
|
|
Antifungal Agents |
|
|
|
Imidazoles
Therapeutics that treat and prevent skin diseases caused by fungi.
Buyer Products:
|
|
|
|
Dermatoses |
|
|
|
Steroidal Anti-Inflammatory Drugs (SAID)
Therapeutics that counteract or suppress inflammation by inhibiting the accumulation of inflammatory cells like leucocytes and macrophages at the inflammation site.
Buyer Products:
Target Products:
|
|
|
|
Diaper Rash |
|
|
|
Zinc Oxide
Therapeutics that treat diaper rash by forming a protective barrier against the skin.
Buyer Products:
Target Products:
|
|
|
|
Pruritus |
|
|
|
Antihistamines
Therapeutics that inhibit inflammation by blocking the action of histamines on tissues.
Buyer Products:
|
|
|
|
Psoriasis |
|
|
|
Tumor Necrosis Factor-Alpha Antagonists (TNF-Alpha Antagonists)
Therapeutics that treat psoriasis by blocking the action of tumor necrosis factor.
Buyer Products:
|
|
|
|
Pigmentation Disorders |
|
|
|
Hyperpigmentation |
|
|
|
Retinoids/Vitamin A Analogs
Therapeutics that treat disorders characterized by darkening of skin by promoting cell differentiation as well as preventing proliferation of cells.
Buyer Products:
|
|
|
|
Ulcers |
|
|
|
Diabetic Foot |
|
|
|
Platelet Derived Growth Factors (PDGF)
Therapeutics that treat foot ulcers by promoting the recruitment of cells involved in tissue repair and also enhancing the formation of granulation tissue.
Buyer Products:
|
|
|
|
Digestive System |
|
|
|
Gall Bladder Disorders |
|
|
|
Cholelithiasis (Gallstones) |
|
|
|
Anticholelithic Agents
Therapeutics that treat gall stones by decreasing the liver's cholesterol synthesis and secretion.
Target Products:
|
|
|
|
Gastrointestinal Tract Disorders |
|
|
|
Gastroduodenal Disorders |
|
|
|
Peptic Ulcers |
|
|
|
Duodenal |
|
|
|
H2 Receptor Antagonists
Therapeutics that treat peptic ulcers by inhibiting the actions of receptors responsible for triggering acid release into the stomach.
Target Products:
|
|
|
|
Proton Pump Inhibitors
Therapeutics that treat peptic ulcers by inhibiting the membrane protein involved in the final steps of triggering acid release into the stomach.
Buyer Products:
|
|
|
|
Ulcer Adhering Agents
Therapeutics that treat peptic ulcers by binding to it and protecting it from further damage.
Target Products:
|
|
|
|
Gastric |
|
|
|
H2 Receptor Antagonists
Therapeutics that treat peptic ulcers by inhibiting the actions of receptors responsible for triggering acid release into the stomach.
Target Products:
|
|
|
|
Proton Pump Inhibitors
Therapeutics that treat peptic ulcers by inhibiting the membrane protein involved in the final steps of triggering acid release into the stomach.
Buyer Products:
|
|
|
|
Zollinger-Ellison Syndrome |
|
|
|
H2 Receptor Antagonists
Therapeutics that treat ulcers by inhibiting the actions of receptors responsible for triggering acid release into the stomach.
Target Products:
|
|
|
|
Proton Pump Inhibitors
Therapeutics that treat ulcers by inhibiting the membrane protein involved in the final steps of triggering acid release into the stomach.
Buyer Products:
|
|
|
|
Gastroesophageal Disorders |
|
|
|
Abdominal Gas |
|
|
|
Acid Neutralizing Agents/Gas Bubble Surface Tension Reducing Agents
Therapeutics that treat abdominal gas by reducing the acidity of the stomach as well as lowering the surface tension of gas bubbles in the bowels.
Buyer Products:
Target Products:
|
|
|
|
Gas Bubble Surface Tension Reducing Agents
Therapeutics that treat abdominal gas by reducing the surface tension of gas bubbles in the bowels.
Buyer Products:
Target Products:
|
|
|
|
Acid Indigestion/Heartburn |
|
|
|
Acid Neutralizing Agents
Therapeutics that treat heartburn by neutralizing stomach acid.
Buyer Products:
Target Products:
|
|
|
|
Acid Neutralizing Agents/Gas Bubble Surface Tension Reducing Agents
Therapeutics that treat indigestion by neutralizing the stomach acid as well as lowering the surface tension of the gas bubbles in the bowels.
Buyer Products:
Target Products:
|
|
|
|
Acid Neutralizing Agents/H2 Receptor Antagonists
Therapeutics that treat heartburn by neutralizing stomach acid and blocking the action of histamine at the H2 receptors.
Buyer Products:
|
|
|
|
H2 Receptor Antagonists
Therapeutics that treat indigestion by blocking the action of histamine at the H2 receptors.
Buyer Products:
Target Products:
|
|
|
|
Erosive Esophagitis |
|
|
|
H2 Receptor Antagonists
Therapeutics that treat Erosive Esophagitis by inhibiting the actions of receptors responsible for triggering acid release into the stomach.
Target Products:
|
|
|
|
Gastroesophageal Reflux Disease (GERD) |
|
|
|
Dopamine Receptor Blocking Agents
Therapeutics that treat Gastroesophageal Reflux Disease (GERD) by blocking dopamine receptor and stimulating gastrointestinal movement without stimulating secretions from the pancreas, stomach or gall bladder.
Buyer Products:
|
|
|
|
H2 Receptor Antagonists
Therapeutics that treat Gastroesophageal Reflux Disease by inhibiting the actions of receptors responsible for triggering acid release into the stomach.
Target Products:
|
|
|
|
Proton Pump Inhibitors
Therapeutics that treat Gastroesophageal Reflux Disease by inhibiting the membrane protein involved in the final steps of triggering acid release into the stomach.
Buyer Products:
|
|
|
|
Nausea/Vomiting |
|
|
|
Antiemetic Agents
Therapeutics that treat nausea or vomiting by acting locally on the hyperactive gastrointestinal wall.
Target Products:
|
|
|
|
Dopamine Receptor Blocking Agents
Therapeutics that treat or prevent nausea and vomiting by blocking the action of dopamine.
Buyer Products:
|
|
|
|
Intestinal Disorders |
|
|
|
Constipation |
|
|
|
Chronic |
|
|
|
Bulk-Forming Agents
Therapeutics that treat constipation by stimulating the formation of bodies of feces that are able to be passed through the bowels.
Target Products:
|
|
|
|
Impacted Bowels |
|
|
|
Hyperosmotic Agents
Therapeutics that treat constipation by causing fluid overload, which in turn induces liquid stool within a short period of time.
Target Products:
|
|
|
|
Stimulants
Therapeutics that treat constipation by stimulating the contraction of bowels by addition of fiber or other substances.
Target Products:
|
|
|
|
Stool Softeners
Therapeutics that treat constipation by increasing the absorption of moisture into feces to form a softer body.
Target Products:
|
|
|
|
Irregular Bowel Movements |
|
|
|
Bulk-Forming Agents
Therapeutics that treat constipation by stimulating the formation of bodies of feces that are able to be passed through the bowels.
Target Products:
|
|
|
|
Stimulants
Therapeutics that treat constipation by stimulating the contraction of bowels by addition of fiber or other substances.
Target Products:
|
|
|
|
Diarrhea |
|
|
|
Adsorbents
Therapeutics that treat diarrhea by promoting the uptake of water from the intestines.
Target Products:
|
|
|
|
Antiperistaltic Agents
Therapeutics that treat diarrhea by inhibiting the wavelike motion of the digestive tract.
Buyer Products:
Target Products:
|
|
|
|
Antiperistaltic Agents/Gas Bubble Surface Tension Reducing Agents
Therapeutics that treat diarrhea by inhibiting the wavelike motion of the intestines as well as reducing the surface tension of gas present in the bowels.
Buyer Products:
|
|
|
|
Antisecretory Agents
Therapeutics that treat diarrhea by bringing fluid movement within the intestine to normal levels.
Target Products:
|
|
|
|
Inflammatory Bowel Disease (IBD) |
|
|
|
Crohn`s Disease |
|
|
|
Tumor Necrosis Factor-Alpha Antagonists (TNF-Alpha Antagonists)
Therapeutics that treat Crohn's Disease by inhibiting the action of Tumor Necrosis Factor (TNF), a key component of the inflammation process.
Buyer Products:
|
|
|
|
Ulcerative Colitis |
|
|
|
Cyclooxygenase Inhibitors (COX Inhibitors)/Lipoxygenase Inhibitors
Therapeutics that treat ulcerative colitis by inhibiting the actions of the two enzymes, cyclooxygenase and lipoxygenase.
Target Products:
|
|
|
|
Tumor Necrosis Factor-Alpha Antagonists (TNF-Alpha Antagonists)
Therapeutics that treat ulcerative colitis by blocking the action of tumor necrosis factor.
Buyer Products:
|
|
|
|
Irritable Bowel Syndrome (IBS) |
|
|
|
Anticholinergic Agents
Therapeutics that treat irritable bowel syndrome by decreasing the liver's cholesterol synthesis and secretion.
Target Products:
|
|
|
|
Rectal Disorders |
|
|
|
Hemorrhoids |
|
|
|
Alpha Adrenergic Receptor Agonists
Therapeutics that treat hemorrhoids by stimulating the alpha adrenergic receptors.
Target Products:
|
|
|
|
Liver Disorders |
|
|
|
Cirrhosis |
|
|
|
Complications |
|
|
|
Edema |
|
|
|
Potassium Sparing Diuretic Agents/Thiazide Diuretic Agents
Therapeutics that treat the accumulation of abnormally large amounts of fluid in subcutaneous tissue by increasing the excretion of sodium and water, but not potassium in urine.
Target Products:
|
|
|
|
Thiazide Diuretic Agents
Therapeutics that treat the accumulation of abnormally large amounts of fluid in subcutaneous tissue by increasing the excretion of sodium, potassium ions, and water in urine.
Target Products:
|
|
|
|
Pancreatic Disorders |
|
|
|
Chronic Pancreatitis |
|
|
|
Enzyme Replacement Therapy
Therapeutics that treat long term problems of pancreas inflammation that lead to decreases in pancreatic enzymes by supplying exogenous pancreatic enzymes.
Buyer Products:
|
|
|
|
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of digestive disorders in early stages of clinical research where human subject is involved.
Buyer Products:
|
|
|
|
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of digestive disorders in very early stages of research where no human subject is involved.
Buyer Products:
|
|
|
|
Endocrinology/Metabolism |
|
|
|
Diabetes |
|
|
|
Induced Complications |
|
|
|
Foot Ulcers |
|
|
|
Platelet Derived Growth Factors (PDGF)
Therapeutics that induce the maturation, growth or reproduction of cells.
Buyer Products:
|
|
|
|
Non-Insulin Dependent Diabetes Mellitus (NIDDM)/Type 2 Diabetes |
|
|
|
Biguanides
Therapeutics that treat abnormally high blood glucose levels by decreasing the production of glucose in the liver, decreasing intestinal absorption of glucose and increasing peripheral uptake and utilization of glucose.
Target Products:
|
|
|
|
Insulin Stimulating Agents (Sulfonylureas)
Therapeutics that treat non-insulin dependent diabetes by stimulating the secretion of insulin.
Target Products:
|
|
|
|
Peroxisome Proliferator-Activated Receptor Agonists (PPAR Agonists)
Products that sensitizes organs to insulin.
Target Products:
|
|
|
|
General Hormone Treatments |
|
|
|
Prednisolones
Therapeutics that treat inflammation by preventing the accumulation of inflammatory cells, like macrophages and leukocytes to the inflammation sites.
Target Products:
|
|
|
|
Prednisones
Therapeutics that treat inflammation by preventing the accumulation of inflammatory cells, like macrophages and leukocytes to the inflammation sites.
Target Products:
|
|
|
|
Hyperglycemia |
|
|
|
Insulin Stimulating Agents (Sulfonylureas)
Therapeutics that stimulate the secretion of insulin.
Target Products:
|
|
|
|
Intermediary Metabolism Disorders |
|
|
|
Gout |
|
|
|
Gouty Arthritis |
|
|
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID) |
|
|
|
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that counteract or suppress inflammation preventing cyclooxygenase activity.
Target Products:
|
|
|
|
Urate Crystalization Inhibitors
Therapeutics that treat gouty arthritis by preventing the deposition of urate crystals in the joints.
Target Products:
|
|
|
|
Urate Resorption Inhibitors
Therapeutics that treat gouty arthritis by preventing the active reabsorption of urate at the renal tubule thus increasing the excretion of urinary acid and lowering serum concentrations of urate.
Target Products:
|
|
|
|
Urate Resorption Inhibitors/Urate Crystallization Inhibitors
Therapeutics that treat gouty arthritis by preventing the active reabsorption of urate at the renal tubule thus increasing the excretion of urinary acid and lowering serum concentrations of urate as well as preventing the deposition of excess urate crystals in the joints.
Target Products:
|
|
|
|
Hyperuricemia |
|
|
|
Urate Resorption Inhibitors
Therapeutics that inhibit the resorption of urate from the kidneys.
Target Products:
|
|
|
|
Xanthine Oxidase Inhibitors
Therapeutics that inhibit the resorption of urate from the kidneys and prevent the precipitation of urate in the joint.
Target Products:
|
|
|
|
Hypercholesterolemia |
|
|
|
Free Fatty Acid Inhibitors
Therapeutics that treat the abnormally high concentrations of cholesterol by inhibiting the release of fatty acids from adipose tissue.
Target Products:
|
|
|
|
HMG CoA Reductase Inhibitors (Statins)
Therapeutics that block cholesterol synthesis by binding a key enzyme in the synthesis process.
Target Products:
|
|
|
|
Hyperlipidemia |
|
|
|
Free Fatty Acid Inhibitors
Therapeutics that inhibit the release of fatty acids from adipose tissue.
Target Products:
|
|
|
|
HMG CoA Reductase Inhibitors (Statins)
Therapeutics that block cholesterol synthesis by binding a key enzyme in the synthesis process.
Target Products:
|
|
|
|
Plasma Triglyceride Reducing Agents (Fibrate Compounds)
Therapeutics that reduce the levels of very low-density lipoprotein and increase levels of high-density lipoproteins.
Target Products:
|
|
|
|
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of endocrinology disorders in early stages of clinical research where human subject is involved.
Buyer Products:
|
|
|
|
Reproductive Disorders |
|
|
|
Amenorrhea |
|
|
|
Progestins
Female sex hormone necessary for the development of the female reproductive system.
Target Products:
|
|
|
|
Hypoestrogenism |
|
|
|
Hormonal Treatments |
|
|
|
Estrogens
Therapeutics that are female sex hormones.
Target Products:
|
|
|
|
Hypogonadism |
|
|
|
Male |
|
|
|
Androgens
Therapeutics that are male sex hormones.
Buyer Products:
Target Products:
|
|
|
|
Menopause |
|
|
|
Estrogens
Therapeutics that are female sex hormones.
Target Products:
|
|
|
|
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of endocrinology disorders in very early stages of research where no human subject is involved.
Buyer Products:
|
|
|
|
Hematology |
|
|
|
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of hematological disorders in early stages of clinical research where human subject is involved.
Buyer Products:
Target Products:
|
|
|
|
Red Blood Cell (RBC) Disorders |
|
|
|
Anemia |
|
|
|
Iron Supplements
Therapeutics that treat conditions characterized by reduced delivery of oxygen to body tissues caused by iron deficiency by replacing missing iron.
Target Products:
|
|
|
|
Recombinant Human Erythropoietins
Therapeutics that treat conditions characterized by reduced delivery of oxygen to body tissues by stimulating red blood cell production.
Buyer Products:
|
|
|
|
Sickle Cell Disease (Sickle Cell Anemia) |
|
|
|
Potassium Channel Inhibitors
Therapeutics that treat anemia by inhibiting potassium channels, thereby preventing dehydration of red blood cells.
Buyer Products:
|
|
|
|
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of hematological disorders in very early stages of research where no human subject is involved.
Buyer Products:
|
|
|
|
Serum Factor Disorders |
|
|
|
Hypercholesterolemia |
|
|
|
Free Fatty Acid Inhibitors
Therapeutics that treat the abnormally high concentrations of cholesterol by inhibiting the release of fatty acids from adipose tissue.
Target Products:
|
|
|
|
HMG CoA Reductase Inhibitors (Statins)
Therapeutics that block cholesterol synthesis by binding a key enzyme in the synthesis process.
Target Products:
|
|
|
|
Hyperglycemia |
|
|
|
Insulin Stimulating Agents (Sulfonylureas)
Therapeutics that stimulate the secretion of insulin.
Target Products:
|
|
|
|
Hyperlipidemia |
|
|
|
Free Fatty Acid Inhibitors
Therapeutics that inhibit the release of fatty acids from adipose tissue.
Target Products:
|
|
|
|
HMG CoA Reductase Inhibitors (Statins)
Therapeutics that block cholesterol synthesis by binding a key enzyme in the synthesis process.
Target Products:
|
|
|
|
Plasma Triglyceride Reducing Agents (Fibrate Compounds)
Therapeutics that reduce the levels of very low-density lipoprotein and increase levels of high-density lipoproteins.
Target Products:
|
|
|
|
Hyperuricemia |
|
|
|
Urate Resorption Inhibitors
Therapeutics that prevents the resorption of urate within the kidneys.
Target Products:
|
|
|
|
Xanthine Oxidase Inhibitors
Therapeutics that treat hyperuricemia by preventing the conversion of hypoxanthine to uric acid.
Target Products:
|
|
|
|
Thrombocyte (Platelet) Disorders |
|
|
|
Thrombocythemia |
|
|
|
Megakaryocyte Maturation Inhibitors
Therapeutics that prevents the maturation of platelet producing cells.
Target Products:
|
|
|
|
Immunology |
|
|
|
Autoimmune Disorders |
|
|
|
Arthritis |
|
|
|
Psoriatic Arthritis |
|
|
|
Monoclonal Antibodies
Therapeutics that treat chronic inflammation of the joints coupled with red, scaly skin patches by
interfering with specific immune pathways implicated in the progression of the disease.
Buyer Products:
|
|
|
|
Tumor Necrosis Factor-Alpha Antagonists (TNF-Alpha Antagonists)
Therapeutics that treat chronic inflammation of the joints coupled with red, scaly skin patches by blocking the action of tumor necrosis factor.
Buyer Products:
|
|
|
|
Rheumatoid Arthritis (RA) |
|
|
|
Analgesics |
|
|
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID) |
|
|
|
Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
Therapeutics that treat pain associated with chronic inflammation of the joints by selectively blocking cyclooxygenase 2 activity.
Target Products:
|
|
|
|
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat pain associated with chronic inflammation of the joints by blocking cyclooxygenase activity.
Buyer Products:
Target Products:
|
|
|
|
Immunotherapy |
|
|
|
Immunosuppressants
Therapeutics that treat chronic inflammation of the joints by inhibiting a full immune response.
Target Products:
|
|
|
|
Monoclonal Antibodies
Therapeutics that treat rheumatoid arthritis by interfering with specific immune pathways implicated in the progression of the disease.
Buyer Products:
|
|
|
|
Tumor Necrosis Factor-Alpha Antagonists (TNF-Alpha Antagonists)
Therapeutics that treat chronic inflammation of the joints by blocking the action of tumor necrosis factor.
Buyer Products:
|
|
|
|
Inflammatory Bowel Disease (IBD) |
|
|
|
Crohn`s Disease |
|
|
|
Tumor Necrosis Factor-Alpha Antagonists (TNF-Alpha Antagonists)
Therapeutics that treat inflammation of the gastrointestinal tract by blocking the action of tumor necrosis factor.
Buyer Products:
|
|
|
|
Ulcerative Colitis |
|
|
|
Cyclooxygenase Inhibitors (COX Inhibitors)/Lipoxygenase Inhibitors
Therapeutics that treat inflammation of the colon and rectum by blocking the action of cyclooxygenase and lipoxygenase.
Target Products:
|
|
|
|
Tumor Necrosis Factor-Alpha Antagonists (TNF-Alpha Antagonists)
Therapeutics that treat ulcerative colitis by blocking the action of tumor necrosis factor.
Buyer Products:
|
|
|
|
Lupus Erythematosus |
|
|
|
Systemic (SLE) |
|
|
|
Hormonal
Therapeutics that treat systemic lupus with hormones.
Target Products:
|
|
|
|
Psoriasis |
|
|
|
Tumor Necrosis Factor-Alpha Antagonists (TNF-Alpha Antagonists) |
|
|
|
Immune Deficiency Disorders |
|
|
|
Human Immunodeficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS) |
|
|
|
Protease Inhibitors
Therapeutics that help manage HIV by binding to and blocking the action of HIV protease, an enzyme necessary for viral replication.
Buyer Products:
|
|
|
|
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of immune disorders in early stages of clinical research where human subject is involved.
Buyer Products:
|
|
|
|
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of immune disorders in very early stages of research where no human subject is involved.
Buyer Products:
|
|
|
|
Infectious Diseases |
|
|
|
Bacterial |
|
|
|
Antibacterial Agents |
|
|
|
Broad Spectrum |
|
|
|
Antibiotics |
|
|
|
Cephalosporin Derivatives
Therapeutics that treat a wide variety of infections by inhibiting bacterial cell wall synthesis.
Target Products:
|
|
|
|
Lincosamides
Therapeutics that treat a wide variety of infections by inhibiting bacterial protein synthesis.
Target Products:
|
|
|
|
Nitroimidazoles
Therapeutics that treat a wide variety of infections by inhibiting bacterial protein synthesis and causing cell death.
Target Products:
|
|
|
|
Quinolones/Fluoroquinolones
Therapeutics that treat a wide variety of infections by promoting breakage of bacterial DNA strands.
Buyer Products:
|
|
|
|
Sulfonamides
Therapeutics that treat a wide variety of bacterial infections by inhibiting folic acid synthesis.
Target Products:
|
|
|
|
Tetracyclines
Therapeutics that treat a wide variety of infections by inhibiting protein synthesis and also causing alterations in cytoplasmic membranes.
Target Products:
|
|
|
|
Narrow Spectrum |
|
|
|
Dermatology |
|
|
|
Skin/Soft Tissue Infections |
|
|
|
Sulfonamides
Therapeutics that treat specific bacterial infections by inhibiting folic acid synthesis.
Target Products:
|
|
|
|
Digestive System |
|
|
|
Heliobacter pylori |
|
|
|
Proton Pump Inhibitors
Therapeutics treat digestive infections caused by Helicobacter pylori bacteria by inhibiting the action of the membrane protein involved in the final steps of triggering acid release into the stomach.
Buyer Products:
|
|
|
|
Periodontitis |
|
|
|
Tetracyclines
Therapeutics that treat bacterial infections of the gums, teeth, and underlying bone by inhibiting protein synthesis and also causing alterations in cytoplasmic membranes.
Buyer Products:
|
|
|
|
Musculoskeletal System |
|
|
|
Skin/Soft Tissue Infections |
|
|
|
Sulfonamides
Therapeutics that treat bacterial infections of non-skeletal tissue usually involving fat, muscle, and skin by inhibiting folic acid synthesis.
Target Products:
|
|
|
|
Respiratory System |
|
|
|
Bronchitis |
|
|
|
Quinolones/Fluoroquinolones
Therapeutics that treat bacterial infections leading to inflammation of the bronchi in the lungs by inhibiting an enzyme vital to bacterial DNA transcription and repair.
Buyer Products:
|
|
|
|
Pneumonia |
|
|
|
Quinolones/Fluoroquinolones
Therapeutics that treat inflammation of the lungs caused by bacterial infection by bacterial infection by promoting breakage of bacterial DNA strands.
Buyer Products:
|
|
|
|
Urology |
|
|
|
Prostatitis |
|
|
|
Quinolones/Fluoroquinolones
Therapeutics that treat a wide variety of infections by promoting breakage of bacterial DNA strands.
Buyer Products:
|
|
|
|
Urinary Tract Infections (UTI) |
|
|
|
Antibacterial Agents (Antibiotics) |
|
|
|
Nitrofurantoins
Therapeutics that treat bacterial infections of the urinary tract by inactivating/altering bacterial proteins and other macromolecules.
Buyer Products:
Target Products:
|
|
|
|
Trimethoprim
Therapeutics that treat bacterial infections of the urethra, urinary bladder, ureters, and kidneys by blocking the action of bacterial dihydrofolate reductase.
Target Products:
|
|
|
|
Vaginitis |
|
|
|
Sulfonamides
Therapeutics that treat inflammation of the mucous membrane of the vagina by inhibiting bacterial folic acid synthesis.
Buyer Products:
|
|
|
|
Helminthic |
|
|
|
Ascariasis (Roundworms) |
|
|
|
Antimicrotubule Agents
Therapeutics that treat helminthic infections by disrupting the cell cycle of the worm.
Buyer Products:
|
|
|
|
Enterobiasis (Pinworms) |
|
|
|
Antimicrotubule Agents
Therapeutics that treat helminthic infections by disrupting the cell cycle of the worm. itching.
Buyer Products:
|
|
|
|
Hookworms |
|
|
|
Antimicrotubule Agents
Therapeutics that treat parasitic infections of the intestines.
Buyer Products:
|
|
|
|
Trichuriasis (Whipworms) |
|
|
|
Antimicrotubule Agents
Therapeutics that treat parasitic infections characterized by large worms attached to the lining of the large intestine.
Buyer Products:
|
|
|
|
Mycological (Fungal) |
|
|
|
Antifungal Agents |
|
|
|
Broad Spectrum |
|
|
|
Azoles |
|
|
|
Imidazoles
Therapeutics that treat fungal infections by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.
Buyer Products:
|
|
|
|
Triazoles
Therapeutics that treat fungal infections by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.
Buyer Products:
|
|
|
|
Narrow Spectrum |
|
|
|
Dermatology |
|
|
|
Candidiasis |
|
|
|
Azoles |
|
|
|
Imidazoles
Therapeutics that treat fungal infections of the skin caused by yeast by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.
Buyer Products:
|
|
|
|
Onychomycosis (Nail) |
|
|
|
Azoles |
|
|
|
Triazoles
Therapeutics that treat fungal infections of the nail by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.
Buyer Products:
|
|
|
|
Tinea Corporis (Ringworm) |
|
|
|
Azoles |
|
|
|
Imidazoles
Therapeutics that treat fungal infections of the skin characterized by scaly, red rings by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.
Buyer Products:
|
|
|
|
Thiocarbamates
Therapeutics that treat fungal infections of the skin characterized by scaly, red rings by stunting the growth of the branching filaments.
Target Products:
|
|
|
|
Tinea Cruris (Jock Itch) |
|
|
|
Azoles |
|
|
|
Imidazoles
Therapeutics that treat fungal infections of the groin and perineum by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.
Buyer Products:
|
|
|
|
Thiocarbamates
Therapeutics that treat fungal infections of the groin and perineum by stunting the growth of the branching filaments.
Target Products:
|
|
|
|
Tinea Pedis |
|
|
|
Azoles |
|
|
|
Imidazoles
Therapeutics that treat fungal infections of the feet by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.
Buyer Products:
|
|
|
|
Thiocarbamates
Therapeutics that treat fungal infections of the feet by stunting the growth of the branching filaments.
Target Products:
|
|
|
|
Tinea Versicolor |
|
|
|
Azoles |
|
|
|
Imidazoles
Therapeutics that treat fungal infections of skin exposed to the sun characterized by patches of depigmentation by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.
Buyer Products:
|
|
|
|
Digestive System |
|
|
|
Mucous |
|
|
|
Candidiasis |
|
|
|
Azoles |
|
|
|
Imidazoles
Therapeutics that treat fungal infections of the secretory lining of the tissues caused by a yeast by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.
Buyer Products:
|
|
|
|
Otolaryngology (Ear/Nose/Throat) |
|
|
|
Oropharyngeal Candidiasis |
|
|
|
Azoles |
|
|
|
Imidazoles
Therapeutics that treat fungal infections of the mucosa caused by yeast by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.
Buyer Products:
|
|
|
|
Urology |
|
|
|
Vaginal Candidiasis |
|
|
|
Azoles |
|
|
|
Imidazoles
Therapeutics that treat fungal infections of the female reproductive organ caused by yeast by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.
Buyer Products:
Target Products:
|
|
|
|
Triazoles
Therapeutics that treat fungal infections of the female reproductive organ caused by yeast by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.
Buyer Products:
Target Products:
|
|
|
|
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of infectious diseases in early stages of clinical research where human subject is involved.
Buyer Products:
|
|
|
|
Protozoal |
|
|
|
Antiprotozoal Agents |
|
|
|
Broad Spectrum |
|
|
|
Nitroimidazoles
Therapeutics that treat infections caused by a wide variety of unicellular organisms by inhibiting protein synthesis and causing cell death.
Target Products:
|
|
|
|
Tetracyclines
Therapeutics that treat infections caused by a wide variety of unicellular organisms by inhibiting protein synthesis and causing cell death.
Target Products:
|
|
|
|
Narrow Spectrum |
|
|
|
Malaria |
|
|
|
Quinines
Therapeutics that treat parasitic infections caused by Plasmodia in red blood cells by disrupting replication and transcription.
Target Products:
|
|
|
|
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of infectious diseases in very early stages of research where no human subject is involved.
Buyer Products:
|
|
|
|
Viral |
|
|
|
DNA Viruses |
|
|
|
Herpesvirus |
|
|
|
Herpes Simplex Type 1 |
|
|
|
Purine Nucleoside Analogs
Therapeutics that treat viral infections characterized by recurrent cold sores and fever blisters by inhibiting replication of viral DNA by incorporating themselves into growing viral DNA stands.
Target Products:
|
|
|
|
Herpes Simplex Type 2 |
|
|
|
Purine Nucleoside Analogs
Therapeutics that treat viral infections characterized by recurring outbreaks of painful genital lesions by inhibiting replication of viral DNA by incorporating themselves into growing viral DNA stands.
Target Products:
|
|
|
|
Varicella Zoster |
|
|
|
Herpes Zoster (Shingles) |
|
|
|
Purine Nucleoside Analogs
Therapeutics that treat viral infections that cause shingles in adults by inhibiting replication of viral DNA by incorporating themselves into growing viral DNA stands.
Target Products:
|
|
|
|
Varicella (Chickenpox) |
|
|
|
Purine Nucleoside Analogs
Therapeutics that treat viral infections that cause chicken pox in children by inhibiting replication of viral DNA by incorporating themselves into growing viral DNA stands.
Target Products:
|
|
|
|
Papillomavirus |
|
|
|
Genital Warts |
|
|
|
Podophyllins
Therapeutics that treat viral infections that cause genital warts by eroding skin lesions.
Target Products:
|
|
|
|
RNA Viruses |
|
|
|
Retrovirus |
|
|
|
Human Immunodeficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS) |
|
|
|
Protease Inhibitors
Therapeutics that help manage HIV by binding to and blocking the action of HIV protease, an enzyme necessary for viral replication.
Buyer Products:
|
|
|
|
Musculoskeletal System |
|
|
|
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of skeletal system disorders in early stages of clinical research where human subject is involved.
Buyer Products:
|
|
|
|
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of skeletal system disorders in very early stages of research where no human subject is involved.
Buyer Products:
|
|
|
|
Skeletal Disorders |
|
|
|
Bone Disorders |
|
|
|
Osteoporosis |
|
|
|
Hormonal Treatments |
|
|
|
Estrogens
Therapeutics that treat osteoporosis by providing female hormones which results in a decrease in the rate of bone loss due to osteoclasts.
Target Products:
|
|
|
|
Osteoclast Bone Resorption Inhibitors
Therapeutics that treat osteoporosis by preventing loss of bone mass due to osteoclasts.
Target Products:
|
|
|
|
Paget`s Disease |
|
|
|
Osteoclast Bone Resorption Inhibitors
Therapeutics that treat paget's disease by inhibiting the loss of bone material by osteoclasts.
Target Products:
|
|
|
|
Joint Disorders |
|
|
|
Ankylosing Spondylitis |
|
|
|
Immunotherapy |
|
|
|
Monoclonal Antibodies
Therapeutics that treat ankylosing spondylitis interfering with specific immune pathways implicated in the progression of the disease.
Buyer Products:
|
|
|
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID) |
|
|
|
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat inflammation by non-specifically inhibiting the action of cyclooxygenase.
Target Products:
|
|
|
|
Tumor Necrosis Factor-Alpha Antagonists (TNF-Alpha Antagonists)
Therapeutics that treat ankylosing spondylitis by blocking the effect of TNF-alpha, a pro-inflammatory molecule.
Buyer Products:
|
|
|
|
Gouty Arthritis |
|
|
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID) |
|
|
|
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat inflammation by inhibiting cyclooxygenase activity.
Target Products:
|
|
|
|
Urate Crystalization Inhibitors
Therapeutics that treat gouty arthritis by preventing the deposition of urate crystals in the joints.
Target Products:
|
|
|
|
Urate Resorption Inhibitors
Therapeutics that treat gouty arthritis by preventing the active reabsorption of urate at the renal tubule thus increasing the excretion of urinary acid and lowering serum concentrations of urate.
Target Products:
|
|
|
|
Urate Resorption Inhibitors/Urate Crystallization Inhibitors
Therapeutics that treat gouty arthritis by preventing the active reabsorption of urate at the renal tubule thus increasing the excretion of urinary acid and lowering serum concentrations of urate as well as preventing the deposition of excess urate crystals in the joints.
Target Products:
|
|
|
|
Osteoarthritis (OA) |
|
|
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID) |
|
|
|
Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
Therapeutics that treat inflammation by specifically inhibiting the action of cyclooxygenase-2.
Target Products:
|
|
|
|
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat inflammation by non-specifically inhibiting the action of cyclooxygenase.
Buyer Products:
Target Products:
|
|
|
|
Substance P Inhibitors
Therapeutics that treat inflammation by preventing the accumulation of Substance P at the inflammation sites.
Target Products:
|
|
|
|
Psoriatic Arthritis |
|
|
|
Monoclonal Antibodies
Therapeutics that treat chronic inflammation of the joints coupled with red, scaly skin patches by
interfering with specific immune pathways implicated in the progression of the disease.
Buyer Products:
|
|
|
|
Tumor Necrosis Factor-Alpha Antagonists (TNF-Alpha Antagonists)
Therapeutics that treat chronic inflammation of the joints by blocking the action of tumor necrosis factor.
Buyer Products:
|
|
|
|
Rheumatoid Arthritis (RA) |
|
|
|
Analgesics |
|
|
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID) |
|
|
|
Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
Therapeutics that treat pain associated with chronic inflammation of the joints by selectively blocking cyclooxygenase 2 activity.
Target Products:
|
|
|
|
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat pain associated with chronic inflammation of the joints by blocking cyclooxygenase activity.
Buyer Products:
Target Products:
|
|
|
|
Immunotherapy |
|
|
|
Immunosuppressants
Therapeutics that treat rheumatoid arthritis by suppressing the immune system.
Target Products:
|
|
|
|
Monoclonal Antibodies
Therapeutics that treat rheumatoid arthritis by interfering with specific immune pathways implicated in the progression of the disease.
Buyer Products:
|
|
|
|
Tumor Necrosis Factor-Alpha Antagonists (TNF-Alpha Antagonists)
Therapeutics that treat chronic inflammation of the joints by blocking the action of tumor necrosis factor.
Buyer Products:
|
|
|
|
Neurology |
|
|
|
Neurological Disorders |
|
|
|
Alzheimer`s Disease |
|
|
|
Acetylcholinesterase Inhibitors
Therapeutics that treat Alzheimer's Disease by preventing the breakdown of a the neurotransmitter, acetylcholine.
Target Products:
|
|
|
|
Acetylcholinesterase Inhibitors/Nicotinic Receptor Modulators
Therapeutics that treat Alzheimer's Disease by preventing the breakdown of a the neurotransmitter, acetylcholine, and by modulating the receptor that binds nicotine.
Buyer Products:
|
|
|
|
Autism |
|
|
|
Monoaminergic Antagonists |
|
|
|
Dementia |
|
|
|
Acetylcholinesterase Inhibitors/Nicotinic Receptor Modulators
Therapeutics that treat dementia by preventing the breakdown of a the neurotransmitter, acetylcholine, and by modulating the receptor that binds nicotine.
Buyer Products:
|
|
|
|
Epilepsy |
|
|
|
Partial Seizures |
|
|
|
Complex |
|
|
|
Adjunctive Therapy |
|
|
|
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Therapeutics that treat complex partial seizures by preventing the uptake of gamma-aminobutyric acid, which prevent nerve activation.
Target Products:
|
|
|
|
Sodium Channel Blocking Agents/Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat complex partial seizures by preventing the uptake of gamma-aminobutyric acid as well as blocking the sodium channels which in turn block the conductance of electrical impulses through the brain.
Buyer Products:
Target Products:
|
|
|
|
Monotherapy |
|
|
|
Barbiturates
Therapeutics that treat complex partial seizures by decreasing excitability of neurons.
Target Products:
|
|
|
|
Sodium Channel Blocking Agents/Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat complex partial seizures by preventing the uptake of gamma-aminobutyric acid as well as blocking the sodium channels which in turn block the conductance of electrical impulses through the brain.
Buyer Products:
|
|
|
|
Simple |
|
|
|
Adjunctive Therapy |
|
|
|
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Therapeutics that treat simple partial seizures by preventing the uptake of gamma-aminobutyric acid which prevents nerve activation.
Target Products:
|
|
|
|
Sodium Channel Blocking Agents/Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat simple partial seizure by both preventing the uptake of gamma-aminobutyric acid which prevents nerve activation as well as blocking the sodium channels which in turn block the conductance of neural impulses.
Buyer Products:
Target Products:
|
|
|
|
Monotherapy |
|
|
|
Barbiturates
Therapeutics that treat simple partial seizures by decreasing excitability of neurons.
Target Products:
|
|
|
|
Sodium Channel Blocking Agents/Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat simple partial seizure by both preventing the uptake of gamma-aminobutyric acid which prevents nerve activation as well as blocking the sodium channels which in turn block the conductance of neural impulses.
Buyer Products:
|
|
|
|
Primary Generalized Seizures |
|
|
|
Absence (Petit Mal) |
|
|
|
Adjunctive Therapy |
|
|
|
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Therapeutics that treat Petit Mal Seizures by preventing the uptake of molecules that prevents nerve activation.
Target Products:
|
|
|
|
Monotherapy |
|
|
|
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Therapeutics that treat Petit Mal Seizures by preventing the uptake of molecules that prevents nerve activation.
Target Products:
|
|
|
|
Akinetic Pattern |
|
|
|
Adjunctive Therapy |
|
|
|
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Therapeutics that treat Akinetic Pattern Seizures by preventing the uptake of molecules that prevents nerve activation.
Target Products:
|
|
|
|
Monotherapy |
|
|
|
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Therapeutics that treat Akinetic
Pattern Seizures by preventing the uptake of molecules that prevents nerve activation.
Target Products:
|
|
|
|
Myoclonic |
|
|
|
Adjunctive Therapy |
|
|
|
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Therapeutics that treat Myoclonic Seizures by inhibiting the uptake of molecules that prevent nerve activation.
Target Products:
|
|
|
|
Monotherapy |
|
|
|
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Therapeutics that treat Myoclonic Seizures by inhibiting the uptake of molecules that prevents nerve activation.
Target Products:
|
|
|
|
Tonic-Clonic (Grand Mal) |
|
|
|
Barbiturates
Therapeutics that treat tonic clonic seizures by acting as sedatives through nonselective suppression of central nervous system activities.
Target Products:
|
|
|
|
Sodium Channel Blocking Agents/Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat simple partial seizure by both preventing the uptake of gamma-aminobutyric acid which prevents nerve activation as well as blocking the sodium channels which in turn block the conductance of neural impulses.
Buyer Products:
|
|
|
|
Headaches |
|
|
|
Tension Type |
|
|
|
Barbiturates/Analgesics/Antipyretics/Opioids/Stimulants
Therapeutics that treat tension type headaches by decreasing the excitability of neurons, decreasing pain by inhibiting the production of prostaglandins as well as stimulating the opioid receptors.
Target Products:
|
|
|
|
Barbiturates/Analgesics/Antipyretics/Stimulants
Therapeutics that treat tension type headaches by decreasing the excitability of neurons and decreasing pain by inhibiting the production of prostaglandins.
Target Products:
|
|
|
|
Barbiturates/Non-Steroidal Anti-Inflammatory Drugs (NSAID)/Opioids/Stimulants
Therapeutics that treat pain by depressing neural activity, preventing inflammation and fever, altering the perception of and emotional response to pain, and stimulating the central nervous system.
Target Products:
|
|
|
|
Barbiturates/Non-Steroidal Anti-Inflammatory Drugs (NSAID)/Stimulants
Therapeutics that treat tension type headaches by decreasing the excitability of neurons as well as decreasing pain by inhibiting the production of prostaglandins.
Target Products:
|
|
|
|
Vascular (Migraine) |
|
|
|
Acute Treatments |
|
|
|
Selective Serotonin Receptor Agonists (Triptans)
Therapeutics that treat vascular/migraine headaches by stimulating the receptor that binds with the neurotransmitter, serotonin.
Buyer Products:
|
|
|
|
Prophylactic Treatments |
|
|
|
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat Migraine by inhibiting stimulation of beta adrenergic receptors.
Target Products:
|
|
|
|
Calcium Channel Blocking Agents
Therapeutics that prevent migraines by blocking calcium channels, which may relieve or prevent reactive vasodilation.
Buyer Products:
|
|
|
|
Sodium Channel Blocking Agents/Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that prevent migraines by both preventing the uptake of gamma-aminobutyric acid which prevents nerve activation, as well as blocking the sodium channels which in turn block the conductance of neural impulses.
Buyer Products:
|
|
|
|
Motion Sickness |
|
|
|
Anticholinergic Agents
Therapeutics that treat motion sickness by selectively deterring actions of the involuntary nervous system.
Target Products:
|
|
|
|
Antivertigo Agents
Therapeutics that prevent the sensation of motion.
Target Products:
|
|
|
|
Spasticity (Spinal Shock) |
|
|
|
Aspartic Receptor Antagonists/Glutamic Receptor Antagonists
Therapeutics that treat Spinal Shock by blocking the receptors for aspartic acid and glutamic acid, both excitatory neurotransmitters.
Target Products:
|
|
|
|
Neuromuscular Disorders |
|
|
|
Myasthenia Gravis (MG) |
|
|
|
Cholinesterase Inhibitors
Therapeutics that treat Myasthenia Gravis by maintaining the transmission of nerve impulses by inhibiting the enzyme that breaks down acetylcholine.
Target Products:
|
|
|
|
Parkinson`s Disease (PD) |
|
|
|
Adjunctive Treatments |
|
|
|
Cholinergic Receptor Blocking Agents
Therapeutics that assist in the treatment of the disorder involving nerve cell loss in portions of the brain that leads to uncontrolled tremors, abnormal posture and speech problems by blocking acetylcholine receptors on neurons.
Target Products:
|
|
|
|
Tourette`s Syndrome |
|
|
|
Dopamine Receptor Blocking Agents
Therapeutics that treat the disorder involving uncontrolled verbal outbursts, ticks and facial expressions by blocking dopamine receptors on the neurons.
Buyer Products:
|
|
|
|
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of nervous system and mental disorders in early stages of clinical research where human subject is involved.
Buyer Products:
|
|
|
|
Psychiatric Disorders |
|
|
|
Anxiety |
|
|
|
Generalized Anxiety Disorder (GAD) |
|
|
|
Antihistamines
Therapeutics that treat anxiety by blocking the action of histamines.
Target Products:
|
|
|
|
Carbamate Derivatives
Therapeutics that treat anxiety by blocking the NMDA receptor thus blocking the effects of excitatory amino acids and suppressing seizure activity.
Target Products:
|
|
|
|
Dopamine Receptor Blocking Agents
Therapeutics that treat anxiety by blocking dopamine receptors.
Target Products:
|
|
|
|
Dopamine Receptor Blocking Agents/Tricyclic Antidepressants
Therapeutic combinations that treat anxiety by blocking dopamine receptors as well as increasing the synaptic concentrations of norepinephrine and serotonin.
Target Products:
|
|
|
|
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat anxiety by enhancing the inhibitory neurotransmitter action of gamma-aminobutyric acid.
Target Products:
|
|
|
|
Tricyclic Compounds
Therapeutics that treat anxiety by increasing the synaptic concentrations of norepinephrine and serotonin.
Target Products:
|
|
|
|
Obsessive Compulsive Disorder (OCD) |
|
|
|
Selective Serotonin Reuptake Inhibitors (SSRI)
Therapeutics that treat Anxiety by selectively preventing the removal of serotonin.
Target Products:
|
|
|
|
Panic Disorder |
|
|
|
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat panic disorder by enhancing the inhibitory neurotransmitter action of gamma-aminobutyric acid.
Target Products:
|
|
|
|
Childhood/Adolescent Disorders |
|
|
|
Attention Deficit Disorder (ADD)/Attention Deficit Hyperactivity Disorder (ADHD) |
|
|
|
Dopamine Receptor Blocking Agents
Therapeutics that treat attention deficit disorder by blocking the dopamine receptors.
Buyer Products:
Target Products:
|
|
|
|
Eating Disorders |
|
|
|
Bulimia |
|
|
|
Selective Serotonin Reuptake Inhibitors (SSRI)
Therapeutics that treat eating disorders by selectively preventing the removal of serotonin.
Target Products:
|
|
|
|
Mood Disorders |
|
|
|
Bipolar Disorders (Manic Depressive Disorders) |
|
|
|
Monoaminergic Antagonists
Therapeutics that treat bipolar disorder by blocking the serotonin and dopamine receptors.
Buyer Products:
|
|
|
|
Sodium Channel Blocking Agents/Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that bipolar disorders by both preventing the uptake of gamma-aminobutyric acid which prevents nerve activation, as well as blocking the sodium channels which in turn block the conductance of neural impulses.
Buyer Products:
|
|
|
|
Tricyclic Compounds
Therapeutics that treat bipolar disorders by increasing the synaptic concentrations of norepinephrine and serotonin.
Target Products:
|
|
|
|
Depression |
|
|
|
Dopamine Receptor Blocking Agents/Tricyclic Antidepressants
Therapeutics that treat depression by increasing the synaptic concentrations of norepinephrine and serotonin and by blocking the receptor for dopamine.
Target Products:
|
|
|
|
Monoamine Oxidase (MAO) Inhibitors
Therapeutics that treat depression by inhibiting the activity of monoamine oxidase, which degrades neurotransmitters.
Target Products:
|
|
|
|
Selective Serotonin Reuptake Inhibitors (SSRI)
Therapeutics that treat depression by selectively preventing the removal of serotonin.
Target Products:
|
|
|
|
Serotonin/Norepinephrine Reuptake Inhibitors
Therapeutics that treat depression by inhibiting the neuronal uptake of serotonin and norepinephrine.
Target Products:
|
|
|
|
Tetracyclic Compounds
Therapeutics that treat depression by increasing the synaptic concentrations of norepinephrine.
Target Products:
|
|
|
|
Tricyclic Compounds
Therapeutics that treat depression by increasing the synaptic concentrations of norepinephrine and serotonin.
Target Products:
|
|
|
|
Schizophrenia |
|
|
|
Dopamine Receptor Blocking Agents
Therapeutics that treat schizophrenia by blocking the dopamine receptors.
Buyer Products:
Target Products:
|
|
|
|
Dopamine Receptor Blocking Agents/Tricyclic Antidepressants
Therapeutic combinations that treat the disorder involving disturbances in thoughts, emotions and reasoning by blocking dopamine receptors as well as increasing the synaptic concentrations of norepinephrine and serotonin.
Target Products:
|
|
|
|
Monoaminergic Antagonists
Therapeutics that treat schizophrenia by blocking the serotonin and dopamine receptors.
Buyer Products:
|
|
|
|
Serotonin/Dopamine Receptor Blocking Agents
Therapeutics that treat schizophrenia by blocking serotonin and dopamine receptors.
Buyer Products:
|
|
|
|
Sleep Disorders |
|
|
|
Insomnia |
|
|
|
Antihistamines
Therapeutics that treat insomnia by preventing the functions of histamine on tissues.
Buyer Products:
|
|
|
|
Antihistamines/Analgesics/Antipyretics
Therapeutics that treat insomnia by preventing the functions of histamine on tissues as well as treating pain and suppressing fever.
Buyer Products:
|
|
|
|
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat insomnia by enhancing the inhibitory action of gamma-aminobutyric acid.
Target Products:
|
|
|
|
Narcolepsy |
|
|
|
Dopamine Receptor Blocking Agents
Therapeutics that treat Narcolepsy by blocking the dopamine receptors.
Target Products:
|
|
|
|
Obstetrics/Gynecology |
|
|
|
Child Birth/Pregnancy |
|
|
|
Hemolytic Disease Of The Newborn (HDN) |
|
|
|
Immunoglobulins
Therapeutics that treat Hemolytic Disease of the Newborn by suppressing the immune response of Rh negative individuals to Rh positive red blood cells.
Buyer Products:
|
|
|
|
Prevention (Contraception) |
|
|
|
Contraceptives (Birth Control) |
|
|
|
Copper-Based
Therapeutics that prevent conception by inducing a foreign body inflammatory response leading to changes in endometrial tissue as well as uterine fluid. The copper released from the device may be responsible for changes in enzyme levels that may also help reduce the activity of sperm.
Buyer Products:
|
|
|
|
Estrogens/Progestins
Therapeutics that prevent conception by decreasing the secretion of gonadotropin-releasing hormone in the hypothalamus, resulting in an anti-ovulatory effect.
Buyer Products:
Target Products:
|
|
|
|
Progestins
Contraceptive Therapeutics that are female sex hormone necessary for the development of the female reproductive system
Buyer Products:
Target Products:
|
|
|
|
Female Genital Disorders |
|
|
|
Infertility |
|
|
|
Hormonal Treatments |
|
|
|
Ovulation Stimulating Agents
Therapeutics that treat infertility by stimulating the ovaries to release a mature egg.
Target Products:
|
|
|
|
Ovarian |
|
|
|
Hypogonadism |
|
|
|
Hormonal Treatments |
|
|
|
Estrogens
These are female sex hormones.
Target Products:
|
|
|
|
Sexual Dysfunction |
|
|
|
Androgens
Therapeutics that treat female sexual dysfunction by providing male sex hormone, such as testosterone, that is important for the normal functioning of the female reproductive system.
Target Products:
|
|
|
|
Vulvovaginal |
|
|
|
Acidity |
|
|
|
Acidity Buffers
Therapeutics that neutralize the effects of acids thus protecting gentle tissue from acidity changes.
Buyer Products:
|
|
|
|
Atrophy |
|
|
|
Hormonal Treatments |
|
|
|
Estrogens
Therapeutics that treat disorders characterized by thinning of the vaginal walls with the female sex hormone estrogen.
Buyer Products:
Target Products:
|
|
|
|
Kraurosis Vulvae |
|
|
|
Estrogens
Therapeutics that treat atrophy of the external female genitalia with estrogens.
Buyer Products:
|
|
|
|
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of female reproductive disorders in early stages of clinical research where human subject is involved.
Buyer Products:
Target Products:
|
|
|
|
Oncology |
|
|
|
Breast Cancer |
|
|
|
Localized |
|
|
|
Topoisomerase II Inhibitors
Therapeutics that treat breast cancer by inhibiting a specific enzyme needed for transcription and replication of DNA.
Buyer Products:
|
|
|
|
Palliative Agents |
|
|
|
Hormonal Treatments |
|
|
|
Estrogens
Therapeutics that treat and manage breast cancer in post-menopausal women by providing female hormones.
Target Products:
|
|
|
|
Dermatology |
|
|
|
Kaposi`s Sarcoma |
|
|
|
Topoisomerase II Inhibitors
Therapeutics that treat and manage cancers of spindle cells by inhibiting a specific enzyme needed for transcription and replication of DNA.
Buyer Products:
|
|
|
|
Digestive System |
|
|
|
Colon Cancer/Colorectal Cancer |
|
|
|
Localized |
|
|
|
Immunomodulators
Therapeutics that treat and manage colorectal cancer by acting as an immunorestorative agent in patients with suppressed immune systems due to chemotherapy.
Buyer Products:
|
|
|
|
Monoclonal Antibodies
Therapeutics that bind to specific receptors on the surface of colorectal cancer cells that inhibit the cancer cells' growth and induce their death.
Buyer Products:
|
|
|
|
Pancreatic Cancer |
|
|
|
Localized |
|
|
|
Farnesyl Transferase Inhibitors
Therapeutics that treat pancreatic cancer by inhibiting the action of farnesyl transferase, an enzyme necessary for cell division.
Buyer Products:
|
|
|
|
Head/Neck Cancer |
|
|
|
Palliative Agents |
|
|
|
Thiophosphate Cytoprotective Agents
Therapeutics that treat nephropathy associated with repeated cisplatin treament for head and neck cancers.
Buyer Products:
|
|
|
|
Hematology |
|
|
|
Leukemia |
|
|
|
Lymphoid |
|
|
|
Chronic |
|
|
|
Hairy Cell |
|
|
|
Antimetabolite Agents |
|
|
|
Adenosine Deaminase Inhibitors
Therapeutics that treat and manage a slowly progressing cancer of lymphoid cells characterized by numerous irregular cytoplasmic projections by inhibiting the transformation of deoxyadenosine into deoxyinosine thereby impairing DNA synthesis as well as leaving the cancer cells unable to repair single stranded DNA breaks.
Buyer Products:
|
|
|
|
Myeloid |
|
|
|
Acute |
|
|
|
Myelogenous (AML) |
|
|
|
Farnesyl Transferase Inhibitors
Therapeutics that treat rapidly progressing cancers of myelogenous cells by inhibiting the action of farnesyl transferase, an enzyme necessary for cell division.
Buyer Products:
|
|
|
|
Palliative Agents |
|
|
|
Xanthine Oxidase Inhibitors
Therapeutics that treat renal toxicity associated with chemotherapy by preventing the formation of uric acid from xanthine.
Target Products:
|
|
|
|
Lymphoma |
|
|
|
Hodgkin`s Disease |
|
|
|
Palliative Agents |
|
|
|
Xanthine Oxidase Inhibitors
Therapeutics that treat renal toxicity associated with chemotherapy for lymphoma characterized by the presence of Reed-Sternberg cells by preventing the formation of uric acid from xanthine.
Target Products:
|
|
|
|
Multiple Myeloma (MM) |
|
|
|
Topoisomerase II Inhibitors
Therapeutics that treat and manage multiple myeloma by inhibiting a specific enzyme needed for transcription and replication of DNA.
Buyer Products:
|
|
|
|
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment and management of cancer in early stages of clinical research where human subject is involved.
Buyer Products:
|
|
|
|
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment and management of cancer and are currently in an early research or preclinical stage of development.
Buyer Products:
|
|
|
|
Respiratory System/Thoracic |
|
|
|
Lung Cancer |
|
|
|
Non Small Cell Lung Cancer (NSCLC) |
|
|
|
Palliative Agents |
|
|
|
Thiophosphate Cytoprotective Agents
Therapeutics that treat nephropathy associated with repeated cisplatin treatment for cancers of the lung including squamous cell carcinoma, adenocarcinoma and large cell carcinoma
Buyer Products:
|
|
|
|
Urology |
|
|
|
Kidney Cancer (Renal Cell Carcinoma) |
|
|
|
Localized |
|
|
|
Vaccines
Therapeutics that are meant to treat and manage primary cancers of the kidneys by eliciting a specific immune response against the cancer cells.
Buyer Products:
|
|
|
|
Ovarian Cancer |
|
|
|
Adenocarcinoma |
|
|
|
Alkylating Agents |
|
|
|
Platinum-Based Agents
Platinum containing therapeutics that treat and manage cancer of cells lining the ovary by interacting with DNA and inhibiting cell division.
Target Products:
|
|
|
|
Transcription Factor Inhibitors
Therapeutics that treat and manage cancer of cells lining the ovary by interfering with DNA transcription, thereby leading to tumor cells destruction.
Buyer Products:
|
|
|
|
Metastatic |
|
|
|
Topoisomerase II Inhibitors
Therapeutics that treat and manage ovarian cancers that have spread beyond their original tumor site by inhibiting a specific enzyme, topoisomerase II, needed for transcription and replication of DNA.
Buyer Products:
|
|
|
|
Palliative Agents |
|
|
|
Alkylating Agents |
|
|
|
Platinum-Based Agents
Platinum containing therapeutics that treat and manage ovarian cancers by interacting with DNA and inhibiting cell division but are not curative.
Target Products:
|
|
|
|
Thiophosphate Cytoprotective Agents
Therapeutics that treat nephropathy associated with repeated cisplatin treatment for cancers of the ovaries.
Buyer Products:
|
|
|
|
Prostate Cancer |
|
|
|
Palliative Agents |
|
|
|
Estrogens
Therapeutics that treat and manage prostate cancer by inhibiting the secretion of luteinizing hormone and affecting the testes so as to decrease serum concentrations of testosterone but are not curative.
Target Products:
|
|
|
|
Gonadotropin Releasing Hormone (GnRH) Agonists
Therapeutics that treat and manage prostate cancer by suppressing the secretion of luteinizing hormone which results in decreased testosterone concentrations but are not curative.
Buyer Products:
|
|
|
|
Gonadotropin Releasing Hormone (GnRH) Antagonists
Therapeutics that treat and manage primary tumors of the prostate gland by blocking the action of gonadotropin releasing hormone and thus decreasing levels of testosterone.
Target Products:
|
|
|
|
Ophthalmology |
|
|
|
Degenerative Disorders |
|
|
|
Dry Eye |
|
|
|
Lubricants
Therapeutics that wet the eye and lubricate the eye.
Target Products:
|
|
|
|
Glaucoma |
|
|
|
Carbonic Anhydrase Inhibitors
Therapeutics that decrease the formation of the fluid of the eye.
Target Products:
|
|
|
|
Cholinergic Agents
Therapeutics that stimulate cholinergic receptors leading to decrease inflow and increased outflow of fluid of the eye.
Buyer Products:
|
|
|
|
Irritation/Inflammation |
|
|
|
Vasoconstricting Agents
Therapeutics that prevent inflammation by constricting the blood vessels.
Target Products:
|
|
|
|
Pain Management |
|
|
|
Anesthesia |
|
|
|
General (Systemic) |
|
|
|
Adjunctive |
|
|
|
Opioids
Therapeutics that treat pain by binding to certain nervous system receptors which alters both the perception of pain as well as the emotional response to pain.
Buyer Products:
|
|
|
|
Local |
|
|
|
Opioids
Therapeutics that treat pain by binding to certain nervous system receptors which alters the both the perception of pain as well as the emotional response to pain.
Buyer Products:
|
|
|
|
Sodium Channel Blocking Agents
Therapeutics that treat pain by blocking the movement of sodium ions and thus the initiation and conduction of nerve impulses across the neuronal membrane.
Buyer Products:
|
|
|
|
Narcotics |
|
|
|
Analgesics/Opioids
Therapeutics that treat pain by binding to certain nervous system receptors which alters the both the perception of pain as well as the emotional response to pain.
Buyer Products:
Target Products:
|
|
|
|
Barbiturates/Analgesics/Antipyretics/Opioids/Stimulants
Therapeutics that treat pain by depressing neural activity, preventing inflammation and fever, altering the perception of and emotional response to pain, and stimulating the central nervous system.
Target Products:
|
|
|
|
Barbiturates/Non-Steroidal Anti-Inflammatory Drugs (NSAID)/Opioids/Stimulants
Therapeutics that treat pain by depressing neural activity, preventing inflammation and fever, altering the perception of and emotional response to pain, and stimulating the central nervous system.
Target Products:
|
|
|
|
Opioids
Therapeutics that treat pain by binding to certain nervous system receptors which alter both the perception of pain as well as the emotional response to pain.
Buyer Products:
Target Products:
|
|
|
|
Non-Narcotics |
|
|
|
Analgesics Combinations |
|
|
|
Analgesics/Antipyretics
Therapeutics that treat pain and fever by inhibiting the action of prostaglandins.
Buyer Products:
Target Products:
|
|
|
|
Barbiturates/Analgesics/Antipyretics/Stimulants
Therapeutic combinations that treat pain by depressing neural activity, preventing inflammation and fever, and stimulating the central nervous system.
Target Products:
|
|
|
|
Gamma-Aminobutyric Acid (GABA) Reuptake Inhibitors
Therapeutics that treat pain by inhibiting the reuptake of GABA, which increases the levels of GABA in the synapses.
Target Products:
|
|
|
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID) |
|
|
|
Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
Therapeutics that treat pain by specifically inhibiting the action of cyclooxygenase-2.
Target Products:
|
|
|
|
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat pain by non-specifically inhibiting the action of cyclooxygenase.
Buyer Products:
Target Products:
|
|
|
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID) Combinations |
|
|
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID)/Decongestants
Therapeutic combinations that produce insensibility or numbness through the inhibition of prostoglandins while also preventing nasal decongestion.
Buyer Products:
|
|
|
|
Skeletal Muscle Relaxing Agents
Therapeutics that treat pain by depressing specific synaptic reflexes preferentially.
Buyer Products:
Target Products:
|
|
|
|
Steroidal Anti-Inflammatory Drugs (SAID)
Therapeutics that treat pain by preventing the accumulation of inflammatory cells, like macrophages and leukocytes to the inflammation sites.
Target Products:
|
|
|
|
Substance P Inhibitors
Therapeutics that treat pain by inhibiting the accumulation of Substance P at the inflammation site.
Target Products:
|
|
|
|
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of pain in early stages of clinical research where human subject is involved.
Buyer Products:
|
|
|
|
Respiratory System |
|
|
|
Lower Respiratory Tract Disorders (Lung Disorders) |
|
|
|
Cystic Fibrosis (CF) |
|
|
|
Complications |
|
|
|
Pancreatic Deficiency |
|
|
|
Enzyme Replacement Therapy
Therapeutics that treat a deficiency of pancreatic enzymes caused by cystic fibrosis by providing exogenous pancreatic enzymes.
Buyer Products:
|
|
|
|
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of respiratory disorders in very early stages of research where no human subject is involved.
Buyer Products:
|
|
|
|
Upper Respiratory Tract Disorders |
|
|
|
Coughs/Colds |
|
|
|
Amphetamines
Therapeutics that treat coughs and colds by helping to relieve nasal congestion.
Target Products:
|
|
|
|
Antihistamines
Therapeutics that inhibit the inflammation by blocking the action of histamines on tissues.
Buyer Products:
Target Products:
|
|
|
|
Antihistamines/Analgesics/Antipyretics
Therapeutics that treat allergic reactions by suppressing inflammation, relieving pain, and reducing fever.
Buyer Products:
|
|
|
|
Antihistamines/Decongestants
Therapeutics that block the inflammatory action of histamines and reduces the amount of mucous build up.
Target Products:
|
|
|
|
Antihistamines/Decongestants/Analgesics/Antipyretics
Therapeutics that treat coughs and colds by suppressing inflammation, reducing mucous build up, relieving pain, and reducing fever.
Buyer Products:
|
|
|
|
Antihistamines/Decongestants/Antitussives
Therapeutics that treat coughs and colds by suppressing inflammation, reducing mucous build up, and relieving or preventing coughs.
Target Products:
|
|
|
|
Antihistamines/Decongestants/Antitussives/Analgesics/Antipyretics
Therapeutics that treat coughs and colds by suppressing inflammation, reducing mucous build up, relieving or preventing coughs, relieving pain, and reducing fever.
Buyer Products:
|
|
|
|
Antitussives
Therapeutics that relieve or prevent coughs.
Buyer Products:
|
|
|
|
Decongestants
Therapeutics that treat coughs and colds by reducing mucous build up.
Buyer Products:
Target Products:
|
|
|
|
Decongestants/Analgesics
Therapeutics that treat coughs and colds by reducing mucous build up and relieving pain.
Buyer Products:
|
|
|
|
Decongestants/Analgesics/Antipyretics
Therapeutics that treat coughs and colds by reducing mucous build up, relieving pain, and reducing fever.
Buyer Products:
|
|
|
|
Decongestants/Antitussives/Analgesics/Antipyretics
Therapeutics that treat coughs and colds by reducing mucous build up, suppressing coughs and relieving pain and fever.
Buyer Products:
|
|
|
|
Decongestants/Antitussives/Expectorants/Analgesics/Antipyretics
Therapeutics that treat coughs and colds by reducing mucous build up, suppressing the cough, helping in the ejection of mucous and helping relieve fever and pain.
Buyer Products:
|
|
|
|
Expectorants
Therapeutics that treat coughs and colds by helping in the ejection of mucous.
Target Products:
|
|
|
|
Nasal Dryness |
|
|
|
Moisturizing Agents
Therapeutics that treat nasal dryness by providing moisture to the nasal passages.
Target Products:
|
|
|
|
Surgery |
|
|
|
Cardiovascular System |
|
|
|
Complications |
|
|
|
Ischemia |
|
|
|
Anticoagulating Agents (Anticoagulants) |
|
|
|
Platelet Aggregation Inhibitors |
|
|
|
Glycoprotein IIb/IIIa Receptor Blocking Agents
These therapeutics prevent the clotting of blood before coronary artery procedures are performed through the skin.
Buyer Products:
|
|
|
|
General |
|
|
|
Complications |
|
|
|
Hemorrhage |
|
|
|
Recombinant Human Erythropoietins
Therapeutics that are used for blood transfusions.
Buyer Products:
|
|
|
|
Restlessness/Apprehension |
|
|
|
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat the nervousness which precedes surgery by increasing the action of gamma aminobutyric acid at the relevant neuroreceptors.
Target Products:
|
|
|
|
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of surgical complications in early stages of clinical research where human subject is involved.
Buyer Products:
|
|
|
|
Toxicology |
|
|
|
Substance Abuse |
|
|
|
Withdrawal |
|
|
|
Alcohol |
|
|
|
Antihistamines
Therapeutics that treat alcohol withdrawal by blocking the H2 receptors and thus the effects of histamines.
Target Products:
|
|
|
|
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat alcohol withdrawal by increasing the effect of GABA at the relevant neuroreceptors.
Target Products:
|
|
|
|
Nicotine (Smoking Cessation) |
|
|
|
Nicotinic Receptor Agonists
Therapeutics that treat nicotine withdrawal by activating nicotine receptors thus reducing cravings for nicotine.
Buyer Products:
Target Products:
|
|
|
|
Transplantation |
|
|
|
Heart |
|
|
|
Rejection Prophylaxis |
|
|
|
Monoclonal Antibodies
Protein-based therapeutics that target specific substances like proteins.
Buyer Products:
|
|
|
|
Hepatic (Liver) |
|
|
|
Rejection Prophylaxis |
|
|
|
Monoclonal Antibodies
Protein-based therapeutics that target specific substances like proteins.
Buyer Products:
|
|
|
|
Renal (Kidney) |
|
|
|
Rejection Prophylaxis |
|
|
|
Monoclonal Antibodies
Protein-based therapeutics that target specific substances like proteins.
Buyer Products:
|
|
|
|
Urology |
|
|
|
Male Genital Disorders |
|
|
|
Penile |
|
|
|
Erectile Dysfunction (Impotence) |
|
|
|
Vasodilatory Agents
Therapeutics that increase blood flow in the penis by dilating blood vessels.
Buyer Products:
|
|
|
|
Premature Ejaculation |
|
|
|
Selective Serotonin Reuptake Inhibitors (SSRI)
Therapeutics that treat premature ejaculation by selectively preventing the removal of serotonin.
Buyer Products:
|
|
|
|
Prostate |
|
|
|
Benign Prostate Hyperplasia (BPH) |
|
|
|
Alpha Adrenergic Receptor Blocking Agents (Alpha Blockers)
Therapeutics that increase blood flow by acting on the alpha adrenergic receptors thus causing the smooth muscle in the prostate to relax and decreasing the constriction on the urinary tract.
Target Products:
|
|
|
|
Testicular |
|
|
|
Failure |
|
|
|
Hormonal Treatments |
|
|
|
Androgens
Therapeutics that treat testicular failure by providing male sex hormones.
Target Products:
|
|
|
|
Hypogonadism |
|
|
|
Androgens
Therapeutics that treat hypogonadism by providing male sex hormones.
Buyer Products:
Target Products:
|
|
|
|
Urological Disorders |
|
|
|
Bladder |
|
|
|
Cystitis |
|
|
|
Anti-Inflammatory Agents
Therapeutics that treat and reduce inflammation of the urinary bladder.
Buyer Products:
|
|
|
|
Neurogenic Bladder Disease |
|
|
|
Anticholinergic Agents
Therapeutics that block the actions of choline and other cholinergic agents.
Buyer Products:
Target Products:
|
|
|
|
Urinary Frequency/Urge Incontinence |
|
|
|
Anticholinergic Agents
Therapeutics that treat the inability to control urinary excretory functions by blocking the actions of choline and other cholinergic agents.
Buyer Products:
Target Products:
|
|
|
|
Muscarinic Receptor Antagonists
Therapeutics that treat the inability to control urinary excretory functions by blocking the action of choline and other cholinergic agents by binding to the muscarinic receptor.
Buyer Products:
|
|
|
|
Kidney (Renal) |
|
|
|
Chronic Renal Failure (CRF) |
|
|
|
Complications |
|
|
|
Anemia |
|
|
|
Recombinant Human Erythropoietins
Therapeutics that treat the condition resulting from the scarcity of red blood cells by inducing the production of red blood cells.
Buyer Products:
|
|
|
|
Edema |
|
|
|
Potassium Sparing Diuretic Agents/Thiazide Diuretic Agents
Therapeutics that treat the accumulation of abnormally large amounts of fluid in subcutaneous tissue by increasing the excretion of sodium and water, but not potassium in urine.
Target Products:
|
|
|
|
Thiazide Diuretic Agents
Therapeutics that treat the accumulation of abnormally large amounts of fluid in subcutaneous tissue by increasing the excretion of sodium, potassium ions, and water in urine.
Target Products:
|
|
|
|
Nephrolithiasis/Renal Calculi (Kidney Stones) |
|
|
|
Calcium |
|
|
|
Xanthine Oxidase Inhibitors
Therapeutics that treat the formation of kidney stones from calcium deposits by reducing uric acid formation through the inhibition of xanthine oxidase.
Target Products:
|
|
|
|
Cystine |
|
|
|
Alkalinizing Agents
Therapeutics that treat the formation of kidney stones by replacing the insoluble Calcium /Magnesium salts with soluble Sodium salts.
Buyer Products:
|
|
|
|
Uric Acid |
|
|
|
Alkalinizing Agents
Therapeutics that treat the formation of kidney stones by replacing the insoluble Calcium /Magnesium salts with soluble Sodium salts.
Buyer Products:
|
|
|
|
Xanthine Oxidase Inhibitors
Therapeutics that inhibit the conversion of hypoxanthine to uric acid, thus preventing the deposition of excess uric acid in the kidneys.
Target Products:
|
|
|
|
Weight Management |
|
|
|
Obesity |
|
|
|
Sympathomimetic Agents
Therapeutics that suppress appetite by stimulating the adrenergic receptors and produce adrenergic chemicals.
Target Products:
|
|
|
|
Wound Management |
|
|
|
Burns |
|
|
|
Complications |
|
|
|
Infections |
|
|
|
Antibacterial Agents (Antibiotics) |
|
|
|
Sulfonamides
Therapeutics that treat bacterial infections in injuries caused by fire or excessive heat by inhibiting folic acid synthesis.
Target Products:
|
|
|
|
Antifungal Agents |
|
|
|
Sulfonamides
Therapeutics that treat fungal infections in injuries caused by fire or excessive heat by inhibiting folic acid synthesis.
Target Products:
|
|
|
|
Ulcers |
|
|
|
Diabetic Foot |
|
|
|
Platelet Derived Growth Factors (PDGF)
Therapeutics that treat foot ulcers by promoting the recruitment of cells involved in tissue repair and also enhancing the formation of granulation tissue.
Buyer Products:
|
|
|
|
Pressure |
|
|
|
Platelet Derived Growth Factors (PDGF)
Therapeutics that treat a local excavation on the surface of tissue caused by sustained pressure and friction by promoting proliferation of new skin cells.
Buyer Products:
|
|
|
|
Healthcare Services |
|
|
|
Support Services |
|
|
|
Consulting
Services providing advice, assistance, and information to a wide range of healthcare companies, including pharmaceutical, medical devices, and health services companies.
Buyer Products:
|
|
|
|
Medical Devices |
|
|
|
Cardiology |
|
|
|
Diagnostic |
|
|
|
Imaging |
|
|
|
X-Ray |
|
|
|
Angiography |
|
|
|
Accessories
Various instruments used to assist in angiography procedures, including transducers, catheters, control syringes, waste systems, contrast management systems, fluid administration sets, and other related items.
Buyer Products:
|
|
|
|
Monitoring |
|
|
|
Accessories |
|
|
|
Output Sensors
Instruments that measure various cardiac outputs, such as blood velocity and pressure. Examples of sensors include bioimpedence, hemodynamic and thermodilution catheters.
Buyer Products:
|
|
|
|
Surgical |
|
|
|
General Procedure |
|
|
|
Accessories |
|
|
|
Access |
|
|
|
Arterial
Instruments used to gain access to the heart's arteries, including aortic pouches, introducer needles, introducers and vessel dilators.
Buyer Products:
|
|
|
|
Guidewires
A small wire-like device that is threaded through a catheter to the site of interest for delivery of another apparatus like a stent.
Buyer Products:
|
|
|
|
Instruments |
|
|
|
Electrical |
|
|
|
Electrosurgical |
|
|
|
Bipolar Attachments
An electrosurgical system that has two electrodes in the tip of the instrument to allow for electrical current to flow out one electrode and then back into the other at the site of contact.
Buyer Products:
|
|
|
|
Irrigation Blowers/Misters
Instruments used to add moisture or aid onto cardiac tissue during surgery.
Buyer Products:
|
|
|
|
Manual Instruments
Devices used to perform general cardiac surgery that do not require electrical power, including retractors, forceps, clamps, scissors, knives and other similar surgical items.
Buyer Products:
|
|
|
|
Procedure/Region Specific |
|
|
|
Arrhythmia |
|
|
|
Electrical Signal Disruption |
|
|
|
Radiofrequency (RF) Ablation |
|
|
|
Catheters
Long, slender, wire-like tube that is inserted in a peripheral blood vessel and proceeds all the way to the heart chamber to perform RF tissue ablation.
Buyer Products:
|
|
|
|
Systems
Complete set of instruments to perform cardiac RF tissue ablation.
Buyer Products:
|
|
|
|
Electrophysiology |
|
|
|
Chamber Mapping Systems |
|
|
|
Catheters
Long slender wire-like devices with multiple electrodes on the end that gets inserted into the heart chamber for electrophysiological studies and chamber mapping.
Buyer Products:
|
|
|
|
Systems
Complete set of instruments used to image the inside of the heart chamber.
Buyer Products:
|
|
|
|
Guiding Catheters
Catheter that is used to guide other instruments into place, usually has some sort of curve or steering mechanism.
Buyer Products:
|
|
|
|
Pacing Catheters
Catheter that is capable of regulating the electrical stimulation rhythm of the heart.
Buyer Products:
|
|
|
|
Cardiopulmonary Support |
|
|
|
Minimally Invasive |
|
|
|
Endovascular Bypass Systems
Minimally invasive device that provides cardiopulmonary support by bypassing the heart.
Buyer Products:
|
|
|
|
Coronary Artery Bypass Graft (CABG) |
|
|
|
Invasive (Open Heart) |
|
|
|
Accessories
Various instruments used to assist in open heart bypass surgery, such as sutures, needles and vessel occluders.
Buyer Products:
|
|
|
|
Grafts |
|
|
|
Restenosis Prevention |
|
|
|
Implants
Devices designed to be implanted around coronary bypass grafts in order to prevent restenosis.
Buyer Products:
|
|
|
|
Manual Instruments
Various devices used to perform open heart bypass surgery that do not require electrical power, such as heart positioners, stablizers and retractors.
Buyer Products:
|
|
|
|
Minimally Invasive |
|
|
|
Endoscopes
Devices designed to visualize body cavities during surgeries.
Buyer Products:
|
|
|
|
Manual Instruments
Manual surgical instruments used to perform minimally invasive coronary bypass surgery, such as retractors, forceps, clamps, clip applicators, stablilizers, bisectors and other similar items.
Buyer Products:
|
|
|
|
Port Access Systems
Trocar type device which is inserted at the site of minimally invasive surgical procedure to allow access to the surgical site with surgical instruments.
Buyer Products:
|
|
|
|
Revascularization |
|
|
|
Atherectomy |
|
|
|
Laser Ablation Angioplasty |
|
|
|
Accessories
Various instruments used to assist in laser removal of arterial blockages.
Buyer Products:
|
|
|
|
Percutaneous Transluminal Coronary Angioplasty (PTCA) |
|
|
|
Catheters |
|
|
|
Balloon |
|
|
|
Over-The-Wire
A balloon catheter that is put into position by passing it over the guidewire all the way to the coronary blockage site of interest.
Buyer Products:
|
|
|
|
Rapid Exchange
An angioplasty balloon catheter that provides flexibility, trackability, tactile feedback, and ease of use.
Buyer Products:
|
|
|
|
Guiding
Catheter used to guide the balloon into place in the coronary artery.
Buyer Products:
|
|
|
|
Restenosis Prevention |
|
|
|
Brachytherapy |
|
|
|
Catheters |
|
|
|
Gamma
Catheters which provide gamma radiation at specific vascular sites to prevent restenosis or narrowing of vessels.
Buyer Products:
|
|
|
|
Stents Systems |
|
|
|
Coated
Stent systems that are coated with pharmaceuticals that aid the stent in preventing restenosis.
Buyer Products:
|
|
|
|
General
Stent systems that are not coated with additional pharmaceuticals indicated to prevent restenosis.
Buyer Products:
|
|
|
|
Valvoplasty |
|
|
|
Accessories
Various instruments used to assist opening blockages that are affecting heart valves such as sutures and needles.
Buyer Products:
|
|
|
|
Manual Instruments
Devices used to perform coronary valvoplasty procedures that do not require electrical power, such as retractors, forceps, clamps, rotators, hooks, scissors, bisectors, trocars, sizers and other similar items.
Buyer Products:
|
|
|
|
Clinical Diagnostics |
|
|
|
Chemistry |
|
|
|
Analyzers |
|
|
|
Automation/Robotics
Equipment used to automate processes in a clinical laboratory.
Buyer Products:
|
|
|
|
Discrete |
|
|
|
Limited Assay
Discrete analyzers with limited test menu.
Buyer Products:
|
|
|
|
Multiple Assay
Multi-System analyzers designed for high throughput generally used in high volume clinical laboratories.
Buyer Products:
|
|
|
|
Home Testing |
|
|
|
Glucose |
|
|
|
Invasive
Devices that generally use blood samples for testing and require a needlestick or pin-prick.
Buyer Products:
|
|
|
|
Test Strips
Specific glucose test devices used with glucose monitors.
Buyer Products:
|
|
|
|
Point of Care Testing |
|
|
|
Cholesterol Screen
Discrete analyzers or test kits which measure cholesterol or cholesterol fractions in patient blood.
Buyer Products:
|
|
|
|
Glucose Monitoring |
|
|
|
Invasive |
|
|
|
Continuous Analysis
Glucose test devices which measure patient glucose levels on a continual basis.
Buyer Products:
|
|
|
|
Random Analysis
Glucose test devices which measure patient glucose levels as a blood sample is obtained.
Buyer Products:
|
|
|
|
Non-Invasive |
|
|
|
Continuous Analysis
Glucose test devices which measure patient glucose levels on a continual basis without the need to obtain patient blood..
Buyer Products:
|
|
|
|
Software
Software designed to assist in the management of patient glucose monitoring.
Buyer Products:
|
|
|
|
Kits |
|
|
|
Cardiac
Test kits used to aid in the diagnosis of heart conditions.
Buyer Products:
|
|
|
|
Reagents |
|
|
|
Calibrators |
|
|
|
Routine Analyte |
|
|
|
Multiple
Calibrators which contain multiple specific analytes used to establish the accuracy of chemistry analyzers.
Buyer Products:
|
|
|
|
Single
Calibrators which contain a specific analyte used to establish the accuracy of chemistry analyzers.
Buyer Products:
|
|
|
|
Test Kits |
|
|
|
Photometric |
|
|
|
Anemia
Photometric test kits which measure for analyses associated anemia in plasma or serum.
Buyer Products:
|
|
|
|
Cardiac |
|
|
|
HDL Cholesterol
High density lipoprotein cholesterol.
Buyer Products:
|
|
|
|
Enzymes
Photometric test kits which quantitatively measure for specific metabolic enzymes in body fluids.
Buyer Products:
|
|
|
|
Routine Metabolic Analytes
Photometric test kits which quantitatively measure for specific metabolic analyses in body fluids.
Buyer Products:
|
|
|
|
Immunoassays |
|
|
|
Analyzers |
|
|
|
Infectious Disease
Immunoassay analyzers designed to test for agents of infectious disease.
Buyer Products:
|
|
|
|
Multiple Assay
Immunoassay analyzer designed to perform multiple assays over multiple modalities.
Buyer Products:
|
|
|
|
Therapeutic Drugs
Immunoassay analyzers designed to test for therapeutic drug levels.
Buyer Products:
|
|
|
|
Reagents |
|
|
|
Calibrators |
|
|
|
Immunoassay
Reagents with known values (standards) designed to adjust parameters on immunoassay instrumentation so as to maximize accuracy of the analysis.
Buyer Products:
|
|
|
|
Therapeutic Drugs
Calibrators used in the measurement of therapeutic drugs.
Buyer Products:
|
|
|
|
Toxicology/Abuse Drugs
Calibrators used in the measurement of drugs of abuse.
Buyer Products:
|
|
|
|
Controls |
|
|
|
Immunoassay
Controls used to verify the accuracy of immuassay test systems.
Buyer Products:
|
|
|
|
Test Kits |
|
|
|
Special/Immuno Chemistry |
|
|
|
Anemia |
|
|
|
Ferritin
Immunoassay test kit which quantitatively measures ferritin in plasma or serum.
Buyer Products:
|
|
|
|
Folate
Immunoassay test kit which quantitatively measures folate in plasma or serum.
Buyer Products:
|
|
|
|
Vitamin B12
Immunoassay test kit which quantitatively measures ferritin in plasma or serum.
Buyer Products:
|
|
|
|
Cancer Marker |
|
|
|
Alpha Fetoprotein (AFP)
Immunoassay test kits which quantitatively measures for alpha feto protein in plasma or serum.
Buyer Products:
|
|
|
|
Breast
Diagnostic assay used to detect specific breast tumor or cancer markers.
Buyer Products:
|
|
|
|
CA 125
Immunoassay test kits which quantitatively measures for CA 125, a tumor marker in plasma or serum.
Buyer Products:
|
|
|
|
CA 15-3
Immunoassay test kits which quantitatively measures for CA 15-3, a tumor marker, in plasma or serum.
Buyer Products:
|
|
|
|
CA 19-9
Immunoassay test kits which quantitatively measures for CA 19-9, a tumor markers in plasma or serum.
Buyer Products:
|
|
|
|
CA 21-1
Immunoassay test kits which quantitatively measures for CA 21-1, a tumor markers in plasma or serum.
Buyer Products:
|
|
|
|
CA 72-4
Test kits for the quantification and detection Tumor Associated Glycoprotein 72 (TAG 72)
Buyer Products:
|
|
|
|
CEA
Immunoassay test kits which quantitatively measures for CEA, carcinoembryonic antigen, in plasma or serum.
Buyer Products:
|
|
|
|
PSA/Prostate Specific Protein
Immunoassay test kits which quantitatively measures for prostate specific antigen or prostate specific protein in plasma or serum.
Buyer Products:
|
|
|
|
Cardiac |
|
|
|
Myocardial Infarction/Heart Failure |
|
|
|
CK-MB
Immunoassay test kits which quantitatively measure creatinine kinase-MB fraction in plasma or serum.
Buyer Products:
|
|
|
|
Myoglobin
Immunoassay test kits which quantitatively measure for myoglobin in plasma or serum.
Buyer Products:
|
|
|
|
Troponin
Immunoassay test kits which quantitatively measure for troponin in plasma or serum.
Buyer Products:
|
|
|
|
Fertility/Reproduction |
|
|
|
B-hCG
Immunoassay test kits which quantitatively measures beta hCG, human chorionic gonadotrophin, in plasma or serum.
Buyer Products:
|
|
|
|
Estradiol
Immunoassay test kits which quantitatively measures estradiol in plasma or serum.
Buyer Products:
|
|
|
|
FSH
Immunoassay test kits which quantitatively measures FSH, follicle stimulating hormone, in plasma or serum.
Buyer Products:
|
|
|
|
Lutenizing Hormone
Immunoassay test kits which quantitatively measures LH, lutinizing hormone, in plasma or serum.
Buyer Products:
|
|
|
|
Progesterone
Immunoassay test kits which quantitatively measures progesterone in plasma or serum.
Buyer Products:
|
|
|
|
Prolactin
Immunoassay test kits which quantitatively measures prolactin in plasma or serum.
Buyer Products:
|
|
|
|
Testosterone
Immunoassay test kits which quantitatively measures testosterone in plasma or serum.
Buyer Products:
|
|
|
|
General Immunodiagnostics |
|
|
|
C Reactive Protein
Immunoassay test kits which test for non specific disease states by testing for C-reactive protein.
Buyer Products:
|
|
|
|
Growth/Bone |
|
|
|
Alkaline Phosphatase Activity
Immunoassay test kits which quantitatively measures alkaline phosphatase activity in plasma or serum.
Buyer Products:
|
|
|
|
Collagens
Immunoassay test kits which quantitatively measures derivatives of collagen in plasma or serum.
Buyer Products:
|
|
|
|
Cortisol
Immunoassay test kits which quantitatively measures cortisol in plasma or serum.
Buyer Products:
|
|
|
|
Therapeutic Drugs
Immunoassay test kits which quantitatively measure for therapeutic drugs in serum or urine using automated instrumentation..
Buyer Products:
|
|
|
|
Thyroid |
|
|
|
Free T3
Immunoassay test kits which quantitatively measure for free T3 hormone in plasma or serum.
Buyer Products:
|
|
|
|
Free T4
Immunoassay test kits which quantitatively measure for free thyoxine hormone in plasma or serum.
Buyer Products:
|
|
|
|
T3 Uptake
Test kits which determine the serums' ability to bind thyroid hormone (T3), a parameter directly linked to the ability to maintain normal thyroid hormone levels.
Buyer Products:
|
|
|
|
Thyroid Stimulating Hormone (TSH)
Kits or reagents designed to detect and quantitate the concentration of Thyroid Stimulating Hormone in human blood samples.
Buyer Products:
|
|
|
|
Total T3
Test kits designed to measure the concentration of Total T3 (protein bound) hormone in human blood specimens.
Buyer Products:
|
|
|
|
Total T4
Immunoassay test kits which quantitatively measure for total thyroxine in plasma or serum.
Buyer Products:
|
|
|
|
Toxicology/Abuse Drugs |
|
|
|
Single Drug Kit
Immunoassay test kits which measure for a specific drug of abuse in body fluids.
Buyer Products:
|
|
|
|
Viral |
|
|
|
HTLV I/II/III
Immunoassay kit which tests for the presence of infectious disease or previous infection caused by the HTLV I, II and III viruses.
Buyer Products:
|
|
|
|
Hepatitis
Immunoassay kits which tests for current or previous infection caused by Hepatitis viruses.
Buyer Products:
|
|
|
|
Human Immunodeficiency Virus (HIV) |
|
|
|
Serum |
|
|
|
EIA
Immunoassay kit which tests for the presence of infectious disease caused by the Human Immunodeficiency Virus in serum or plasma using EIA methodologies.
Buyer Products:
|
|
|
|
Genotyping
Tests that "fingerprint" HIV according to chromosomal makeup in order to track specific strains.
Buyer Products:
|
|
|
|
Western Blot
Immunoassay kit which tests for the presence of infectious disease caused by the Human Immunodeficiency Virus in serum or plasma using western blot methodologies.
Buyer Products:
|
|
|
|
Specimen Collection |
|
|
|
Blood |
|
|
|
Capillary |
|
|
|
Lancets
Sharps type of device used to puncture the skin in order to collect a capillary blood sample.
Buyer Products:
|
|
|
|
Dental |
|
|
|
Treatment |
|
|
|
Periodontic |
|
|
|
Gum Pocket Sealants
Sealants which are applied topically to the gum area to aid in gum healing.
Buyer Products:
|
|
|
|
Drug Delivery |
|
|
|
Implants |
|
|
|
Subcutaneous
Products incorporating implant technology that have the potential to
deliver drugs to subcutaneous sites for systemic therapy or to specific tissues.
Buyer Products:
|
|
|
|
Infusion Therapy |
|
|
|
Delivery Systems |
|
|
|
Elastomeric Infusors
Infusion delivery system designed for small-volume fluid transmission (home use).
Buyer Products:
|
|
|
|
Insulin |
|
|
|
Components
Accessories designed to help patients to control insulin levels, such infusion sets, inserters and reservoirs.
Buyer Products:
|
|
|
|
Pumps |
|
|
|
External
External pump that delivers insulin to the patient.
Buyer Products:
|
|
|
|
Vascular Access |
|
|
|
Extended In Dwelling Catheters |
|
|
|
Introducers
Medical devices designed for introducing vascular access.
Buyer Products:
|
|
|
|
Peripheral Intravenous Catheters |
|
|
|
Safety Catheters
Catheters designed to protect healthcare workers from accidental needle punctures.
Buyer Products:
|
|
|
|
Standard
Non-ported peripheral intravenous catheters.
Buyer Products:
|
|
|
|
Percutaneous (Subcutaneous/Intramuscular/Intravenous) |
|
|
|
Syringes |
|
|
|
Specialty |
|
|
|
Insulin
Syringes designed for the delivery of insulin for diabetic patients
Buyer Products:
|
|
|
|
Transdermal |
|
|
|
Iontophoresis/Electrotransport |
|
|
|
Patch-Integrated
Transdermal delivery systems which utilize a epidermal patch for iontophoretic drug delivery
Buyer Products:
|
|
|
|
Needle Free Injection Systems
Medical devices which generate a highly-pressurized jet of medication for direct delivery through the skin; also known as jet-injectors
Buyer Products:
|
|
|
|
Patches
Medical patches applied to the skin which mediate sustained release of medications through the skin
Buyer Products:
Target Products:
|
|
|
|
Gastroenterology |
|
|
|
Surgical |
|
|
|
General Procedure |
|
|
|
Minimally Invasive/Oral Percutaneous Rectal |
|
|
|
Instruments |
|
|
|
Manual Instruments
Devices that perform minimally invasive gastrointestinal surgery that do not require an electrical power source, including balloon inflators, dilators, biopsy forceps, polypectomy snares, injection needles, retrieval baskets/forceps and other similar items.
Buyer Products:
|
|
|
|
Procedure Specific |
|
|
|
Obesity
Instrumentation designed specifically to treat obesity either by electrical stimulation of the stomach or by physically reducing size of stomach.
Buyer Products:
|
|
|
|
Region Specific |
|
|
|
Biliary |
|
|
|
Balloon Dilation Systems
A system that uses a balloon to push apart parts of the body.
Buyer Products:
|
|
|
|
Large Intestine/Colon |
|
|
|
Instruments |
|
|
|
Manual |
|
|
|
Trays/Kits
Packaged instruments and holding receptacle for instruments used in minimally invasive intestinal procedures.
Buyer Products:
|
|
|
|
Stomach |
|
|
|
Instruments |
|
|
|
Trays/Kits
Packaged instruments and holding receptacle for instruments used in minimally invasive gastric procedures.
Buyer Products:
|
|
|
|
General Surgery |
|
|
|
Invasive |
|
|
|
Accessories |
|
|
|
Drainage
Medical instruments used to provide drainage in the surgical area, including access kits, catheters, evacuator kits and reservoirs.
Buyer Products:
|
|
|
|
Guidewires
Guidewires used to lead other medical devices into place during surgical procedures
Buyer Products:
|
|
|
|
Tourniquet Systems
A medical device designed to compress the peripheral vessels to slow down or halt the bleeding process; traditionally composed of a band-type material and a tightening mechanism
Buyer Products:
|
|
|
|
Autotransfusion |
|
|
|
Systems
Complete medical systems used for the collection, storage, and infusion of blood during autotransfusions
Buyer Products:
|
|
|
|
Instruments |
|
|
|
Electrical |
|
|
|
Electrosurgical |
|
|
|
Attachments/Handpieces |
|
|
|
Bipolar
Electrosurgical equipment that utilize bipolar technology in which the electric current flows between the two tips of the instrument, including cutting/coagulating probes, forceps and clamps.
Buyer Products:
|
|
|
|
Monopolar
Electrosurgical equipment which utilize the monopolar technology, in which the electric current flows between the instrument's electrode to the dispersive grounding pad, including scissors, bisectors, forceeps, clamps and cutting probes.
Monopolar electrosurgical instruments used to grasp and retain tissue during electrosurgical procedures
Buyer Products:
|
|
|
|
Generators |
|
|
|
Bipolar
Electrical generators designed to produce current for bipolar electrosurgical equipment
Buyer Products:
|
|
|
|
Radiofrequency/Ultrasonic
Electrosurgical instruments that utilize radiofrequency energy to perform surgical procedures.
Buyer Products:
|
|
|
|
Manual Instruments
Medical devices used manually by surgeons to perform invasive general surgical procedures, such as scalpels, curettes, dissectors, elevators, forceps, osteotomes, retractors, bissectors and other similar items.
Buyer Products:
|
|
|
|
Procedure/Region Specific |
|
|
|
Hernia Repair |
|
|
|
Grafts/Mesh
Mesh or soft tissue used to repair the opening in an abnormal hernia.
Buyer Products:
|
|
|
|
Surgical-Site Treatments |
|
|
|
Anti-Adhesives/Anti-Scarring |
|
|
|
Membranes
Membrane-based products applied during interventional procedures to prevent adhesion to medical devices or to prevent scarring of the surgical sites
Buyer Products:
|
|
|
|
Closure |
|
|
|
Fascia/Subcuticular Staples
Staple-based products used to close-up openings in the layer immediately beneath the skin and encompassing the tissue.
Buyer Products:
|
|
|
|
Skin Staples
Staple-based products used to close-up skin openings during interventional procedures
Buyer Products:
|
|
|
|
Sutures/Loops
Thread-like material used for stitching up an interventional area for surgical procedures, including both absorbable and non-absorbable materials. Sutures that biodegrade and are absorbed in the body after surgical procedures.
Buyer Products:
|
|
|
|
Sealants |
|
|
|
Adhesives
Glue based products used to seal tissue during surgical procedures
Buyer Products:
|
|
|
|
Hemostatic |
|
|
|
Hemostats
Instruments designed to close off vessels during surgical procedures.
Buyer Products:
|
|
|
|
Sponges
Microfibrillar sponge used when conventional hemostasis procedures are not effective.
Buyer Products:
|
|
|
|
Topical
Topical mixture used when conventional hemostasis procedures are not effective.
Buyer Products:
|
|
|
|
Minimally Invasive |
|
|
|
Accessories |
|
|
|
Access
Devices used to access certain areas in the region between the diaphragm and pelvis, such as trocars and blunt ports.
Buyer Products:
|
|
|
|
Insufflation Systems
Systems which control air flow by inflating the abdominal cavity during laproscopic procedures.
Buyer Products:
|
|
|
|
Sutures/Loops
Sutures used in laproscopic procedures.
Buyer Products:
|
|
|
|
Instruments |
|
|
|
Manual |
|
|
|
Endoscopic Instruments
Manual instruments used during laproscopic procedures, such as forceps, retractors, clips, cutters and other similar items.
Buyer Products:
|
|
|
|
Suturers
Devices which provide mechanism of suturing during laproscopic procedures.
Buyer Products:
|
|
|
|
Procedure/Region Specific |
|
|
|
Cholecystectomy |
|
|
|
Manual Instruments
Instruments used in minimally invasive removal of the gall bladder.
Buyer Products:
|
|
|
|
Hernia Repair |
|
|
|
Instruments |
|
|
|
Trays/Kits
Pre-packaged kits which contain needed supplies to perform hernia repair.
Buyer Products:
|
|
|
|
Thorocoscopy |
|
|
|
Accessories |
|
|
|
Access
Surgical instruments used to probe and explore tissue in the thoracic cavity
Buyer Products:
|
|
|
|
Medical Supplies |
|
|
|
Safety and Sterilization |
|
|
|
Safety |
|
|
|
Provider Protection
Medical clothing and protective gear designed to provide protection to healthcare providers.
Buyer Products:
|
|
|
|
Waste Management
Products used to control and contain biohazardous materials, such as chemical waste, fluid waste, and solid waste. These products may include bags, containers, and other more advanced waste treatment systems.
Buyer Products:
|
|
|
|
Sterilization |
|
|
|
Accessories
Cleaning agents and ancillary products designed to sterilize medical products. Accessories include aerators, biological indicators, Bowie Dick test, chemical indicators, detergents, indicator tapes and other similar items.
Buyer Products:
|
|
|
|
Systems
Cleaning systems that use chemicals, steam and other sanitatry methods to sterilize medical products and supplies.
Buyer Products:
|
|
|
|
Tools/Supplies Protection
Devices used to prepare, store and handle surgical devices, which include covers, wraps, tray liners, pouches, cassettes and others.
Buyer Products:
|
|
|
|
Surgical |
|
|
|
Surgical Preparatory Accessories
Ancillary products designed to clean, prepare and organize surgical instruments and procedures, such as brushes, wipes, cleaners, instrument holders, guards/covers, drapes and other similar items.
Buyer Products:
|
|
|
|
Surgical Supplies/Tools
Devices used to aid or perform surgical functions such surgical lights, surgical markers, surgical table, positioners, towels, stockinette, sanitation agents, and other similar items.
Buyer Products:
|
|
|
|
Treatment |
|
|
|
Ambulatory Assist |
|
|
|
Wheelchairs
Chairs mounted on two sets of wheels designed to provide mobility to patients.
Buyer Products:
|
|
|
|
Wound Management/First Aid |
|
|
|
Cleaning/Healing Devices
Devices used to clean and facilitate healing of wounds, such bandages, dressings, cleansers, anti-infective ointments, sponges, cold compresses and other similar items.
Buyer Products:
|
|
|
|
Drainage/Hydration
Medical devices designed to irrigate, moisturize and remove excess fluids from wounds and wound surface.
Buyer Products:
|
|
|
|
Skin Closure
Medical devices used for the mechanical closure/reattachment of the skin surface during interventional procedures, such as staples, sutures, tapes and topical skin adhesives.
Buyer Products:
|
|
|
|
Neurology |
|
|
|
Surgical |
|
|
|
General Procedure |
|
|
|
Cerebrospinal Fluid (CSF) Management |
|
|
|
External Drainage |
|
|
|
Catheters
A long slender wire-like tube device that allows spinal fluid to drain through it out of the body.
Buyer Products:
|
|
|
|
Drainage Systems
Systems designed to facilitate spinal fluid drainage, often including catheters, valves and monitors.
Buyer Products:
|
|
|
|
Intracranial Pressure (ICP) Systems
Sensors that are planted within brain cavities such as the meninges in order to monitor brain fluid pressure.
Buyer Products:
|
|
|
|
Implanted Drainage |
|
|
|
Valves
A device that provides the ability to open or close a tube through which spinal fluid flows.
Buyer Products:
|
|
|
|
Instruments |
|
|
|
Electrical |
|
|
|
Electrosurgical |
|
|
|
Bipolar Attachments
An electrosurgical system that has two electrodes in the tip of the instrument to allow for electrical current to flow out one electrode and then back into the other at the site of contact.
Buyer Products:
|
|
|
|
Monopolar Attachments
An electrosurgical instrument that uses electrical current as the cutting or coagulation force by way of one electrode passing electricity into the body and it leaving via a grounding pad.
Buyer Products:
|
|
|
|
Neuroendoscopes
A device that allows for the visual inspection of any cranial cavity by means of an long fiber optic viewing instrument with a light on the end.
Buyer Products:
|
|
|
|
Manual Instruments
Devices that are used in neurological surgery that do not require electrical power, such as drills, curettes, dissectors, forceps, hooks, retractors, bissectors and other similar items.
Buyer Products:
|
|
|
|
Procedure Specific |
|
|
|
Cerebral Aneurysm Clips
A little clamp-like device used to treat extrusions or bulges in brain arteries or veins.
Buyer Products:
|
|
|
|
Cerebral Embolization |
|
|
|
Embolization Material
Various agents such as gelfoam, silastic, metal, or fat that is used to plug up a bleeding brain artery or vein.
Buyer Products:
|
|
|
|
Guidewires
Guidewires for use specifically in the neurovascular area, generally in the treatment of cerebral emboli.
Buyer Products:
|
|
|
|
MicroCatheters
Catheters specifically designed to reach small vessels within the brain in order to facilitate delivery of medication or therapeutic devices to diseased or damaged brain tissue.
Buyer Products:
|
|
|
|
Region Specific |
|
|
|
Brain |
|
|
|
Dural Grafts
Grafts designed to replace and/or repair damaged or diseased dural tissue.
Buyer Products:
|
|
|
|
Cranium |
|
|
|
Craniotomy |
|
|
|
Instruments |
|
|
|
Electrical |
|
|
|
Craniotomy Kits
Instruments and implements designed for the opening of the skull in order to facilitate brain surgery.
Buyer Products:
|
|
|
|
Handpieces
Various instruments that attach to a driver or power source and allow the surgeon to perform certain surgical procedures like boring holes or cutting into the skull.
Buyer Products:
|
|
|
|
Fixation |
|
|
|
Cranioplasty
Devices that hold together pieces of the skull for healing or plug up a surgical hole in the skull for healing purposes.
Buyer Products:
|
|
|
|
Sets
Complete sets of instruments used to patch up holes or surgical incisions made in the skull.
Buyer Products:
|
|
|
|
Obstetrics/Gynecology |
|
|
|
Surgical |
|
|
|
General Procedure |
|
|
|
Ablation
Surgical devices designed to vaporize tissues. In this case, these devices are mostly used for ablating the lining of the uterus to mitigate menorrhagia.
Buyer Products:
|
|
|
|
Endoscopic |
|
|
|
Colposcopic |
|
|
|
Instruments |
|
|
|
Electrical |
|
|
|
Electrosurgical |
|
|
|
Bipolar Attachments
An electrosurgical system that has two electrodes in the tip of the instrument to allow for electrical current to flow out one electrode and then back into the other at the site of contact.
Buyer Products:
|
|
|
|
Manual Instruments
Instruments used to perform surgery on the cervix that do not require electrical power,
such as forceps, curettes, hooks, speculums, ligature carriers, retractors and other similar items.
Buyer Products:
|
|
|
|
Hysteroscopic |
|
|
|
Accessories |
|
|
|
Irrigation Systems
Devices that flush out waste using a liquid, usually water.
Buyer Products:
|
|
|
|
Sleeves/Sheaths
A sheath like device that covers the resectoscope which is used to view the inner cavity of the uterus.
Buyer Products:
|
|
|
|
Instruments |
|
|
|
Electrical |
|
|
|
Hysteroscopes
Device used to examine the inner cavity of the uterus through a fiberoptic telescope inserted through the vagina and cervical canal.
Buyer Products:
|
|
|
|
Laparoscopic |
|
|
|
Manual Instruments
Surgical instruments designed for use in conjunction with laparoscopy that do not require electrical power, such as cannulas, trocars, clamps, morcellators, needles, scissors and other similar items.
Buyer Products:
|
|
|
|
Resectoscopic |
|
|
|
Instruments |
|
|
|
Electrical |
|
|
|
Electrosurgical |
|
|
|
Bipolar Attachments
An electrosurgical system that has two electrodes in the tip of the instrument to allow for electrical current to flow out one electrode and then back into the other at the site of contact.
Buyer Products:
|
|
|
|
Resectoscopes
Medical device which permits direct viewing and access to the uterine cavity for the purposes of performing hysteroscopic surgical procedures.
Buyer Products:
|
|
|
|
Region Specific |
|
|
|
Cervical |
|
|
|
Catheters
Catheters designed specifically to be inserted through the cervix to faciliate various procedures (e.g. embryo transfer).
Buyer Products:
|
|
|
|
Uterine |
|
|
|
Catheters
A slender wire-like tube device that allows access to the uterine cavity.
Buyer Products:
|
|
|
|
Treatment |
|
|
|
Procedure Specific |
|
|
|
Contraception |
|
|
|
Diaphragm
Medical device inserted into the vagina to cover the opening to the uterus for use as birth control by women.
Buyer Products:
|
|
|
|
Region Specific |
|
|
|
Bladder
Device used to treat bladder problems.
Buyer Products:
|
|
|
|
Pelvic
Devices used after pelvic surgery.
Buyer Products:
|
|
|
|
Oncology |
|
|
|
Surgical |
|
|
|
Biopsy |
|
|
|
General Procedure |
|
|
|
Instruments |
|
|
|
Electrical |
|
|
|
Imaging-Guided Breast Biopsy Systems
Uses 3-D images constructed from x-ray, ultrasound or MRI images to locate and remove breast tumors.
Buyer Products:
|
|
|
|
Ophthalmology |
|
|
|
Surgical |
|
|
|
General Procedure |
|
|
|
Accessories
Components used to assist in a variety of ophthalmic surgeries, such as light probes, light source, sutures, needles and other similar items.
Buyer Products:
|
|
|
|
Instruments |
|
|
|
Manual Instruments
Devices used to perform surgery on the eye or related area that do not require electrical power, such as blades, scalpels, cannulas, curettes, forceps, retractors, speculums and other similar items.
Buyer Products:
|
|
|
|
Treatment |
|
|
|
Dry Eye |
|
|
|
Lubricants
Devices used to alleviate low level of moisture in eye tissue by adding fluid.
Target Products:
|
|
|
|
Vision Correction |
|
|
|
Contact Lenses |
|
|
|
Soft |
|
|
|
Specialty |
|
|
|
Conventional |
|
|
|
Tints
Contact lenses that alter the color of the eye.
Buyer Products:
|
|
|
|
Extended Wear |
|
|
|
Astigmatism (Toric)
Disposable, extended wear, soft contact lenses designed to correct astigmatism
Buyer Products:
|
|
|
|
Presbyopia (Bifocal)
Extended wear contact lenses that address a defect of vision consequent upon advancing age, provide near sight and far sight relief and can be disposed of after a specified period of time.
Buyer Products:
|
|
|
|
Standard |
|
|
|
Daily Disposable
Contact lenses that are disposable on a daily basis. No cleaning required. No overnight wear.
Buyer Products:
|
|
|
|
Extended Wear
Lenses may be worn overnight for up to three months. No cleaning required.
Buyer Products:
|
|
|
|
Orthopedics |
|
|
|
Surgical |
|
|
|
General Procedure |
|
|
|
Invasive |
|
|
|
Accessories |
|
|
|
Bone Cement Kits
Materials and tools used to cement orthopedic implants.
Buyer Products:
|
|
|
|
Bone Tunnel Suture Protectors
Devices used to protect sutures from damage due to movement.
Buyer Products:
|
|
|
|
Drainage Systems
Devices used to drain fluids during and after open orthopedic procedures.
Buyer Products:
|
|
|
|
Mesh
Materials used to maintain the reconstructed space by providing initial stability and allowing maximum transfer of physiological loads to the graft material.
Buyer Products:
|
|
|
|
Patient Positioners |
|
|
|
Instruments |
|
|
|
Electrical |
|
|
|
Handpiece/Drill
Instruments used to drill holes in bone.
Buyer Products:
|
|
|
|
Saws
Instruments used to saw the bone.
Buyer Products:
|
|
|
|
Manual Instruments
Mechanical instruments used in musculoskeletal surgical procedures, such as blades, curettes, broaches, shavers, elevators, tensioners, osteotomes, retractors, rongeurs and other similar items.
Buyer Products:
|
|
|
|
Minimally Invasive/Arthroscopic |
|
|
|
Accessories |
|
|
|
Irrigation |
|
|
|
Cannulas
Catheter like device used to deliver irrigation during arthroscopic surgery.
Buyer Products:
|
|
|
|
Instruments |
|
|
|
Electrical |
|
|
|
Electrosurgical |
|
|
|
Bipolar Attachments
Electrosurgical equipment in which the electric current flows between the two tips of the instrument and do not require grounding pads to surgically process live tissues.
Buyer Products:
|
|
|
|
Instrument Systems
Orthopedic instruments used for arthroscopic surgical procedures usually sold as a package.
Buyer Products:
|
|
|
|
Manual Instruments
Mechanical instruments used in arthroscopic surgical procedures, such as biopsy systems, blades, scalpels, bone harvesters, forceps, clamps, bisectors, suture punch and other similar items.
Buyer Products:
|
|
|
|
Procedure Specific |
|
|
|
Fixation |
|
|
|
Bone |
|
|
|
External |
|
|
|
General
External fixation devices that can be used to fix a variety of fractures.
Buyer Products:
|
|
|
|
Specific |
|
|
|
Hip/Femur
External fixation devices used to immobilize hip or femur fractures.
Buyer Products:
|
|
|
|
Pelvis
External fixation devices used to immobilize pelvis fractures.
Buyer Products:
|
|
|
|
Tibia/Fibula
External fixation devices used to immobilize tibia or fibia fractures.
Buyer Products:
|
|
|
|
Upper Extremities
External fixation devices used to immobilize fractures of the upper extremities.
Buyer Products:
|
|
|
|
Internal |
|
|
|
Absorbable |
|
|
|
General
Internal absorbable fixation devices that can be used to fix a variety of fractures.
Buyer Products:
|
|
|
|
Specific |
|
|
|
Ankle/Foot
Internal absorbable fixation devices used to immobilize ankle or foot fractures.
Buyer Products:
|
|
|
|
Knee
Internal absorbable fixation device used to immobilize knee fractures.
Buyer Products:
|
|
|
|
Upper Extremities
Internal absorbable fixation devices used to immobilize fractures of the upper extremities.
Buyer Products:
|
|
|
|
Metallic |
|
|
|
General
Internal metallic fixation devices or systems that can be used to immobilize various types of bone fractures.
Buyer Products:
|
|
|
|
Specific |
|
|
|
Ankle/Foot
Devices used to repair or fuse the ankle.
Buyer Products:
|
|
|
|
Hip/Femur
Internal metallic fixation devices used to immobilize hip or femur fractures.
Buyer Products:
|
|
|
|
Spine
Internal metallic fixation devices used to immobilize spine fractures.
Buyer Products:
|
|
|
|
Upper Extremities
Internal metallic fixaion devices used to immobilize fractures of the upper extremities.
Buyer Products:
|
|
|
|
Soft Tissue |
|
|
|
Anchors/Screws |
|
|
|
Absorbable |
|
|
|
General
Absorbable anchors/screws used to attach soft tissue to the bone in a variety of regions.
Buyer Products:
|
|
|
|
Specific |
|
|
|
Ankle/Foot
Absorbable anchors/screws used to attach soft tissue to the ankle or foot bone.
Buyer Products:
|
|
|
|
Hand
Absorbable anchors/screws used to attach soft tissue to the hand bones.
Buyer Products:
|
|
|
|
Knee
Absorbable anchors/screws used to attach soft tissue to the knee bones.
Buyer Products:
|
|
|
|
Shoulder
Absorbable anchors/screws used to attach soft tissue to the shoulder bones.
Buyer Products:
|
|
|
|
Metallic |
|
|
|
General
Metal devices used to attach soft tissue to the bone in a variety of regions.
Buyer Products:
|
|
|
|
Specific |
|
|
|
Ankle/Foot
Metal devices used to attach soft tissue to the ankle/foot bones.
Buyer Products:
|
|
|
|
Hand
Metal devices used to attach soft tissue to the hand bones.
Buyer Products:
|
|
|
|
Knee
Metal devices used to attach soft tissue to the knee bones.
Buyer Products:
|
|
|
|
Shoulder
Metal devices used to attach soft tissue to the shoulder bones.
Buyer Products:
|
|
|
|
Suture/Hook Repair Systems |
|
|
|
General
Suture anchors used to attach soft tissue to bone in a variety of regions.
Buyer Products:
|
|
|
|
Joint Replacement/Reconstruction |
|
|
|
Accessories |
|
|
|
Allografts |
|
|
|
Bone
Bone obtained from cadavers to compensate for excessive bone removal.
Buyer Products:
|
|
|
|
Restrictors
Materials used to reinforce cements applied to the fractured area.
Buyer Products:
|
|
|
|
Xenografts
Surgical grafts produced from non-human biological material, often used to compensate for excessive bone or tissue removal.
Buyer Products:
|
|
|
|
Ankle |
|
|
|
Total Ankle Systems
Devices used to replace the entire ankle joint.
Buyer Products:
|
|
|
|
Elbow |
|
|
|
Total Elbow Systems
Devices used to replace the entire ankle joint.
Buyer Products:
|
|
|
|
Hand |
|
|
|
Finger
Devices used to replace or reconstruct finger joints.
Buyer Products:
|
|
|
|
Total Wrist Systems
Devices used to replace the entire wrist joint.
Buyer Products:
|
|
|
|
Hip |
|
|
|
Hemi-Arthroplasty |
|
|
|
Acetabular |
|
|
|
Bipolar
Devices designed to replace both acetabulum.
Buyer Products:
|
|
|
|
Unipolar
Devices designed to replace one acetabulum.
Buyer Products:
|
|
|
|
Femoral
Devices used to replace the ball in the hip joint.
Buyer Products:
|
|
|
|
Instrument Systems
Instruments used to facilitate either product insertion or removal.
Buyer Products:
|
|
|
|
Revision Systems |
|
|
|
Acetabular
Devices used to revise the socket in a previously replaced hip joint.
Buyer Products:
|
|
|
|
Femoral
Devices used to revise the ball in a previously replaced hip joint.
Buyer Products:
|
|
|
|
Total Hip Replacement Systems
Devices used to replace the entire hip joint.
Buyer Products:
|
|
|
|
Knee |
|
|
|
Instrument Systems
Instruments used to facilitate either product insertion or removal.
Buyer Products:
|
|
|
|
Revision Systems
Devices used to revise a previously implanted knee replacement.
Buyer Products:
|
|
|
|
Total Knee Replacement Systems
Devices used to replace the entire knee joint.
Buyer Products:
|
|
|
|
Unicompartmental Replacement
Devices used to replace a portion of the knee joint as opposed to a total knee replacement.
Buyer Products:
|
|
|
|
Shoulder |
|
|
|
Hemi-Arthroplasty |
|
|
|
Humeral Head
Devices used to replace the humeral component of the shoulder.
Buyer Products:
|
|
|
|
Instrument Systems
A complete set of surgical instruments used for arthroscopic shoulder surgery.
Buyer Products:
|
|
|
|
Total Shoulder Replacement Systems
Devices used to replace the entire shoulder joint.
Buyer Products:
|
|
|
|
Spine |
|
|
|
Instrument Systems
Instruments used to facilitate either product insertion or removal.
Buyer Products:
|
|
|
|
Spinal Arthroplasty |
|
|
|
Lumbar Disc Replacement
Devices used to replace the lumbar discs.
Buyer Products:
|
|
|
|
Spinal Implants |
|
|
|
Bone Growth Stimulators
Implantable devices that utilize electromagnetic frequencies to stimulate bone growth.
Buyer Products:
|
|
|
|
Spinal Fusions
Devices used to fuse together two or more vertebrae in the spine.
Buyer Products:
|
|
|
|
Region Specific |
|
|
|
Knee |
|
|
|
Instruments |
|
|
|
Manual |
|
|
|
Graft Fixation/Harvesting Systems
Devices used to attach grafts to existing tissue.
Buyer Products:
|
|
|
|
Tunnel Placement Guides
Devices used to guide the placement of knee tunnels for ligament insertion during knee ligament repair surgeries
Buyer Products:
|
|
|
|
Treatment |
|
|
|
Braces/Supports |
|
|
|
Active
Braces that can be worn during physical activity to support ankle, elbow, arm, knee, shoulder and wrist.
Buyer Products:
|
|
|
|
Compression Nylon/Elastic/Neoprene
Braces comprised of nylon, elastic and neoprene worn to support a variety of musculoskeletal injuries, such the ankle, elbow, knee, back, thigh, wrist and other body parts.
Buyer Products:
|
|
|
|
Passive/Orthosis
Apparatus used to support, align, prevent, or correct deformities or to improve the function of movable parts of the body, such as the ankle, elbow, foot, hip, knee, spine, writs and other body parts.
Buyer Products:
|
|
|
|
Cushioning Devices
Devices designed to provide cushioning to the orthopedic injuries.
Buyer Products:
|
|
|
|
Fracture Immobilization |
|
|
|
Braces
Braces used to immobilize bone fractures of the extremities, including hand, wrist, humeral, ulnar, tibial and fibular fractures.
Buyer Products:
|
|
|
|
Casting
Devices and components used to immobilize bone fractures with fiberglass or plaster, such as cast shoes, cast removals, pads, splints and tapes.
Buyer Products:
|
|
|
|
Pain Management |
|
|
|
General Purpose |
|
|
|
Cold Therapy
Devices that use cold temperatures to ease pain associated with musculoskeletal injuries.
Buyer Products:
|
|
|
|
Joint/Region Specific |
|
|
|
Knee |
|
|
|
Viscosupplementation
Devices used to mimic the synovial fluid in the knee joint in order to relieve pain associated with osteoarthritis.
Buyer Products:
|
|
|
|
Rehabilitation Therapy |
|
|
|
Continuous Passive Motion (CPM)
Devices that provide controlled and continuous movement to body joints without requiring muscular exertion from the patient.
Buyer Products:
|
|
|
|
Plastic/Reconstructive Surgery |
|
|
|
Surgical |
|
|
|
Procedure/Region Specific |
|
|
|
Skin Grafts |
|
|
|
Artificial Skin |
|
|
|
Acellular
Skin grafts that are do not consist of living human cells.
Buyer Products:
|
|
|
|
Radiology |
|
|
|
Nuclear |
|
|
|
Gamma Camera |
|
|
|
Contrast Agents |
|
|
|
Radionuclides |
|
|
|
Injectable
A liquid form of radionuclide contrast agent that is introduced into the body by way of a needle.
Buyer Products:
|
|
|
|
Transfusion Medicine |
|
|
|
Immunohematology |
|
|
|
Automated Blood Typing
Analyzers used to automate the blood typing process.
Buyer Products:
|
|
|
|
Blood Bank Lab Information System
Information systems designed for use in a clinical blood bank which must be FDA approved for use.
Buyer Products:
|
|
|
|
Non-Automated Typing |
|
|
|
Reagents |
|
|
|
Anti-Human Globulin
Solution containing antibodies against multiple human blood cell antigens used in clinical blood banks.
Buyer Products:
|
|
|
|
Antibody Enhancement Media
Media solutions used to enhance antigen/antibody reactions in blood banking procedures.
Buyer Products:
|
|
|
|
Antibody Identification
Reagents used to identify specific antibodies in blood banking procedures.
Buyer Products:
|
|
|
|
Antibody Screening |
|
|
|
Check Cells
Blood cells coated with human immunoglobulin antigens use for quality control procedures in clinical blood banks.
Buyer Products:
|
|
|
|
Controls
Devices used to verify performance of reagents and systems in the clinical blood bank.
Buyer Products:
|
|
|
|
Fetal Screen
Kits used to test for fetal blood cells in the maternal blood circulation as a measure of fetal sensitization to the mothers blood during childbirth.
Buyer Products:
|
|
|
|
Monoclonal Antibody |
|
|
|
ABO Blood Group
Antibodies used for typing blood into the major antigenic blood groups.
Buyer Products:
|
|
|
|
Rh Blood Group
Antibodies used for determining the D antigen on red blood cells.
Buyer Products:
|
|
|
|
Special Blood Grouping
Antibodies used for special blood typing
Buyer Products:
|
|
|
|
Reverse Cell Typing
Specific blood cell groups used to determine the type blood group antibodies present in a patients serum.
Buyer Products:
|
|
|
|
Solid Phase
A type of testing media used to detect antigen/antibody reactions in clinical blood banks.
Buyer Products:
|
|
|
|
Urology |
|
|
|
Diagnostic |
|
|
|
Monitoring |
|
|
|
Urodynamic Monitors
Diagnostic systems used to monitor the function of the urinary system.
Buyer Products:
|
|
|
|
Surgical |
|
|
|
General Procedure |
|
|
|
Invasive |
|
|
|
Instruments |
|
|
|
Retractors
Surgical instruments used retract or move organs or tissue to access specific organs.
Buyer Products:
|
|
|
|
Procedure/Region Specific |
|
|
|
Prostate |
|
|
|
Benign Prostatic Hyperplasia (BPH) |
|
|
|
Instruments |
|
|
|
Electrical |
|
|
|
Laser Systems
Devices that utilize the natural oscillations of atoms or molecules between energy levels for generating coherent electromagnetic radiation to be used as a cutting or coagulation force.
Buyer Products:
|
|
|
|
Vascular |
|
|
|
Diagnostic |
|
|
|
Imaging |
|
|
|
X-Ray |
|
|
|
Angiography |
|
|
|
Accessories
Various instruments used to assist in angiography procedures, including transducers, catheters, control syringes, waste systems, contrast management systems, fluid administration sets, and other related items.
Buyer Products:
|
|
|
|
Surgical |
|
|
|
General Procedure |
|
|
|
Accessories |
|
|
|
Guidewires
Surgical instruments used to lead other medical devices such as catheters into specific areas of the blood vessels
Buyer Products:
|
|
|
|
Introducers
Devices used to provide percutaneous introduction of catheters, interventional devices, and temporary pacing leads into the vasculature.
Buyer Products:
|
|
|
|
Instruments |
|
|
|
Manual Instruments
Devices used to perform general vascular surgery that do not require electrical power, including balloon dissection systems, retractors, forceps, clamps, scissors, needles, tunnelers, valvuotomes and other similar surgical items.
Buyer Products:
|
|
|
|
Occlusion |
|
|
|
Catheters
Surgical catheters used to block/stop the flow of blood during vascular procedures
Buyer Products:
|
|
|
|
Vessel Harvesting |
|
|
|
Instrument Sets
Instruments and holding receptacle for instruments used in vessel harvesting procedures, such as hooks, illuminators, ligature clips and other similar items.
Buyer Products:
|
|
|
|
Procedure/Region Specific |
|
|
|
Patency |
|
|
|
Intravascular Filters
Intravascular filters placed in the vena cava (veins that deliver deoxygenated blood from the periphery to the atrium of the heart)
Buyer Products:
|
|
|
|
Thrombolytic/Embolytic Catheters
Intravascular catheters used to break up plaque build-up and obstructions in blood vessels; thrombus and embolus are composed primarily of platelets/fibrin and platelets/leukocytes combinations respectively.
Buyer Products:
|
|
|
|
Percutaneous Transluminal Angioplasty (PTA) |
|
|
|
Catheters |
|
|
|
Balloon
Catheters equipped with an expanding balloon at the tip
Buyer Products:
|
|
|
|
Guiding
Catheters used to guide the balloon catheter in place.
Buyer Products:
|
|
|
|
Restenosis Prevention |
|
|
|
Stents Systems |
|
|
|
Biliary Tract
Stent inserted into the biliary tract in the liver to prevent future obstruction.
Buyer Products:
|
|
|
|
Iliac Vessels
Stents placed into the iliac arteries to prevent future obstruction; iliac arteries carry the blood from the abdominal aorta to the pelvic region and the lower extremities
Buyer Products:
|
|
|
|
Peripheral
Stents designed to be placed in peripheral blood vessels.
Buyer Products:
|
|
|
|
Nutritional Health |
|
|
|
Dietary/Naturopathic Supplements |
|
|
|
General Health
Products consisting of dietary/naturopathic supplements that are intended to support general health.
Buyer Products:
Target Products:
|
|
|
|
Nutraceuticals |
|
|
|
Cardiovascular Health
Products that may reduce blood cholesterol level when consumed regularly.
Buyer Products:
|
|
|
|
Outsourced Services |
|
|
|
Analytical Services
The Analytical Services Subsector includes outsourced services that utilize analytical instruments to analyze biological and chemical samples.
Target Products:
|
|
|
|
Development/Manufacturing Services |
|
|
|
Chemistry Services
Outsourced companies that provide medicinal chemistry, organic synthesis, process research, cGMP synthesis, and analytical services to the biopharmaceutical industry.
Target Products:
|
|
|
|
Contract Manufacturing Organizations (CMO) |
|
|
|
Pharmaceuticals |
|
|
|
Active/Intermediate Chemicals
Intermediate and active ingredient contract manufacturing organizations that produce large quantities of small molecule compounds for use in final dosage forms.
Buyer Products:
Target Products:
|
|
|
|
Final Dosage Forms
Contract Manufacturing Organizations (CMO) that produce large quantities of drug products in final dosage forms ready to be sold to end users.
Buyer Products:
Target Products:
|
|
|
|
Contract Research Organizations (CRO) |
|
|
|
Limited Service |
|
|
|
Preclinical
Limited Service Contract Research Organizations that design, manage, and monitor animal studies of new therapeutics. In addition to animal studies, these limited service companies also provide formulation development services.
Target Products:
|
|
|
|
Drug Delivery Technology |
|
|
|
Oral Delivery |
|
|
|
Osmotic
Drug Delivery Technologies utilizing an osmotic mechanism for sustained release of the drugs.
Buyer Products:
|
|
|
|
Transmucosal |
|
|
|
Polymer-Based
Drug Delivery Technologies used to deliver drugs using a polymer based matrix to hold/enclose the drug.
Buyer Products:
|
|
|
|
Parenteral/Injectable Delivery |
|
|
|
Lipid Based
Drug Delivery Technology used to deliver drugs in a liposomal/lipid formulation.
Buyer Products:
|
|
|
|
Topical Delivery |
|
|
|
Bioadhesives
Drug Delivery Technology used to deliver drugs by adhering to the required delivery area.
Buyer Products:
|
|
|
|
Osmotic
Drug Delivery Technology that uses an osmotic mechanism for sustained release of the drugs.
Buyer Products:
|
|
|
|
Drug Discovery Services |
|
|
|
Lead Discovery/Validation/Optimization |
|
|
|
Combinatorial Chemistry Libraries
Drug discovery companies that provide biopharmaceutical companies a library of combinatorial chemical compounds used for testing.
Buyer Products:
|
|
|
|
Combinatorial Services
Drug discovery companies that provide biopharmaceutical companies combinatorial chemistry services.
Buyer Products:
|
|
|
|
High Throughput Screening (HTS)
Bioanalytical services that allow for the biological testing of up to 10,000 compounds each day.
Buyer Products:
|
|
|
|
Target Discovery/Validation |
|
|
|
Services
Drug discovery services that discover and validate drug targets for the development of novel biopharmaceutical drugs.
Buyer Products:
|
|
|
|
Manufacturing |
|
|
|
Consumer Manufacturing |
|
|
|
Food, Beverage and Agriculture |
|
|
|
Food |
|
|
|
Sweets/Snacks |
|
|
|
Sugar/Sweetener
Processing of sugarcane and beet into refined sugar and sugar based syrups, as well as non-sugar sweetener production.
Buyer Products:
|
|
|
|
Personal Care and Cleaning Products |
|
|
|
Absorbent Products
Absorbent products, including tampons, pads, and diapers.
Buyer Products:
|
|
|
|
Hair Care
Companies engaged in the manufacturing of hair care products, such as shampoo, conditioner, hair dye, hair spray, styling gel, and mousse. Also includes hair accessories, such as pins, clips, and curlers.
Buyer Products:
|
|
|
|
Oral Care
Oral Care products, including Toothpaste, Mouthwash, and denture adhesive.
Buyer Products:
|
|
|
|
Skin Care
Companies engaged in the manufacturing of skin care products, such as suntan lotion, skin lotion, sanitizer, shaving cream, and moisturizer. Also includes manufacturers of non-electrical shaving equipment.
Buyer Products:
|
|
- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.
- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.
- Sector Participation. Denotes that the company develops products in this line of business.
Relationship Details
Key Competitors
| Name | Dir | Percent | Market Cap. | P/E Ratio (TTM) | Fwd P/E | P/R Ratio (TTM) | Fwd P/Rev | Price To Tang. Book Value | |
|---|---|---|---|---|---|---|---|---|---|
| Overlap | |||||||||
Pfizer Inc.
|
|
n/a | 197,233.738 | 18.27 | 13.50 | 4.17 | 4.14 | 9.26 | |
|
Novartis AG (ADR)
|
|
n/a | 134,289.621 | 23.59 | 18.57 | 3.84 | 3.66 | 3.61 | |
|
Tyco International Ltd.
|
|
n/a | 53,228.745 | 15.99 | 14.73 | 1.37 | 1.31 | 11.32 | |
|
Barr Pharmaceuticals, Inc.
|
|
n/a | 6,136.557 | 18.16 | 17.53 | 4.67 | 4.17 | n/a | |
|
Endo Pharmaceuticals
|
|
n/a | 4,526.068 | 20.77 | 21.28 | 4.92 | 4.93 | 6.68 | |
|
New River Pharmaceuticals, Inc.
|
|
n/a | 963.193 | n/a | -55.09 | 35.91 | 22.77 | 963,193.25 | |
|
Axcan Pharma Inc. (USA)
|
|
n/a | 631.310 | 14.16 | 17.85 | 2.20 | 2.26 | 12.42 | |
|
Noven Pharmaceuticals, Inc.
|
|
n/a | 537.299 | 53.42 | 35.38 | 10.54 | 8.45 | 3.84 | |
|
Pain Therapeutics, Inc.
|
|
n/a | 387.262 | n/a | 96.44 | 18.98 | 6.59 | 5.84 | |
|
Impax Laboratories Inc.
|
|
n/a | 371.378 | 739.66 | 6.46 | 3.30 | 1.68 | 6.33 | |
|
Indevus Pharmaceuticals
|
|
n/a | 329.693 | n/a | -5.47 | 7.27 | 6.86 | -2.24 | |
|
Medicure Inc. (USA)
|
|
n/a | 127.873 | n/a | n/a | 722.67 | n/a | 12.84 | |
|
Oscient Pharmaceuticals Corporation
|
|
n/a | 120.110 | n/a | -1.33 | 3.92 | 2.51 | -1.03 | |
|
Spectrum Pharmaceuticals, Inc.
|
|
n/a | 86.339 | n/a | n/a | 149.76 | n/a | 1.53 | |
|
Immtech Pharmaceuticals, Inc.
|
|
n/a | 84.086 | n/a | n/a | 20.82 | n/a | 6.15 | |
|
Javelin Pharmaceuticals Inc.
|
|
n/a | n/a | n/a | -9.27 | n/a | n/a | n/a | |
| Buyer | |||||||||
|
Pfizer Inc.
|
|
n/a | 197,233.738 | 18.27 | 13.50 | 4.17 | 4.14 | 9.26 | |
|
GlaxoSmithKline plc (ADR)
|
|
n/a | 157,749.428 | 16.17 | 15.59 | 3.62 | 3.73 | 17.12 | |
| Target | |||||||||
|
Pfizer Inc.
|
|
n/a | 197,233.738 | 18.27 | 13.50 | 4.17 | 4.14 | 9.26 | |
|
Johnson & Johnson
|
|
n/a | 188,429.910 | 17.37 | 17.41 | 3.67 | 3.55 | 6.86 | |
|
Novartis AG (ADR)
|
|
n/a | 134,289.621 | 23.59 | 18.57 | 3.84 | 3.66 | 3.61 | |
|
Tyco International Ltd.
|
|
n/a | 53,228.745 | 15.99 | 14.73 | 1.37 | 1.31 | 11.32 | |
|
Teva Pharmaceutical Industries Ltd (ADR)
|
|
n/a | 26,074.362 | 1,055.64 | 15.89 | 3.97 | 3.09 | -846.57 | |
|
Barr Pharmaceuticals, Inc.
|
|
n/a | 6,136.557 | 18.16 | 17.53 | 4.67 | 4.17 | n/a | |
|
Endo Pharmaceuticals
|
|
n/a | 4,526.068 | 20.77 | 21.28 | 4.92 | 4.93 | 6.68 | |
- Defined by the Company
- Defined by Others
Dependent Suppliers
| Name | Dir | Percent | Market Cap. | P/E Ratio (TTM) | Fwd P/E | P/R Ratio (TTM) | Fwd P/Rev | Price To Tang. Book Value | |
|---|---|---|---|---|---|---|---|---|---|
| Overlap | |||||||||
|
Elan Corporation, plc (ADR)
|
|
n/a | 6,415.669 | n/a | -19.55 | 11.89 | 10.65 | -9.44 | |
|
inVentiv Health Inc.
|
|
n/a | 842.790 | 14.77 | 21.66 | 1.28 | 1.17 | -20.21 | |
|
Genelabs Technologies
|
|
n/a | 21.738 | n/a | n/a | 3.18 | n/a | -27.76 | |
| Buyer | |||||||||
|
Neurochem Inc. (USA)
|
|
100.00% | 523.632 | n/a | -8.23 | 160.33 | 99.56 | 15.28 | |
|
PreMD Inc.(USA)
|
|
100.00% | 64.659 | n/a | n/a | 45.60 | n/a | -102.11 | |
|
Icagen, Inc.
|
|
69.00% | 22.172 | n/a | -0.75 | 2.56 | 2.33 | 0.87 | |
|
Immunicon Corp.
|
|
53.00% | 137.119 | n/a | -6.67 | 20.74 | 13.86 | 4.24 | |
|
Alkermes, Inc.
|
|
49.70% | 1,662.415 | 102.66 | -136.17 | 8.60 | 7.71 | 10.13 | |
|
SurModics, Inc.
|
|
46.00% | 713.106 | 37.68 | 27.36 | 10.43 | 9.93 | 5.24 | |
|
Symmetry Medical Inc.
|
|
33.20% | 450.482 | 14.24 | 17.69 | 1.71 | 1.70 | 4.69 | |
|
Millennium Pharmaceuticals, Inc.
|
|
17.00% | 3,310.905 | n/a | -87.42 | 5.84 | 7.00 | 6.08 | |
|
Millipore Corporation
|
|
15.00% | 3,460.995 | 39.11 | 22.75 | 3.33 | 2.87 | 4.52 | |
|
Forward Industries, Inc.
|
|
12.00% | 33.490 | 7.27 | n/a | 0.82 | n/a | 1.37 | |
|
IGI, Inc.
|
|
11.00% | 14.911 | n/a | n/a | 5.58 | n/a | 7.05 | |
|
Sunesis Pharmaceuticals, Inc.
|
|
8.50% | 145.531 | n/a | -4.74 | 9.26 | 8.03 | 1.91 | |
|
Anika Therapeutics, Inc.
|
|
8.00% | 141.993 | 26.22 | 31.70 | 4.69 | 4.59 | 3.41 | |
|
GTC Biotherapeutics, Inc.
|
|
7.00% | 81.045 | n/a | -2.87 | 16.11 | 10.42 | 3.98 | |
|
GenVec, Inc.
|
|
1.80% | 62.440 | n/a | n/a | 2.24 | n/a | 2.33 | |
|
Genentech, Inc.
|
|
n/a | 86,373.982 | 52.80 | 44.02 | 11.03 | 9.68 | 13.41 | |
|
Amgen, Inc.
|
|
n/a | 78,791.131 | 29.28 | 18.23 | 5.95 | 5.53 | 47.35 | |
|
American Express Company
|
|
n/a | 64,703.332 | 18.16 | 18.02 | 2.52 | 2.41 | 6.18 | |
|
Johnson Controls, Inc.
|
|
n/a | 14,647.849 | 15.28 | 14.82 | 0.48 | 0.46 | 39.38 | |
| Target | |||||||||
|
Genelabs Technologies
|
|
4.90% | 21.738 | n/a | n/a | 3.18 | n/a | -27.76 | |
|
Elan Corporation, plc (ADR)
|
|
n/a | 6,415.669 | n/a | -19.55 | 11.89 | 10.65 | -9.44 | |
|
inVentiv Health Inc.
|
|
n/a | 842.790 | 14.77 | 21.66 | 1.28 | 1.17 | -20.21 | |
- Defined by the Company
- Defined by Others
Key Customers
| Name | Dir | Percent | Market Cap. | P/E Ratio (TTM) | Fwd P/E | P/R Ratio (TTM) | Fwd P/Rev | Price To Tang. Book Value | |
|---|---|---|---|---|---|---|---|---|---|
| Buyer | |||||||||
|
Wyeth
|
|
n/a | 63,595.794 | 16.78 | 15.21 | 3.27 | 3.18 | 6.73 | |
|
Mylan Laboratories Inc.
|
|
n/a | 4,433.358 | 21.05 | 15.83 | 3.44 | 3.17 | 6.63 | |
|
Intuitive Surgical, Inc.
|
|
n/a | 3,560.044 | 34.83 | 53.59 | 11.98 | 10.24 | 9.56 | |
|
IDEXX Laboratories, Inc.
|
|
n/a | 2,787.825 | 33.41 | 33.40 | 4.07 | 3.90 | 12.45 | |
|
PDL BioPharma Inc.
|
|
n/a | 2,112.165 | n/a | -183.70 | 5.94 | 5.05 | 20.19 | |
|
Andrx Corporation
|
|
n/a | 1,728.521 | 184.87 | 32.64 | 1.73 | 1.59 | 2.27 | |
|
Owens & Minor, Inc.
|
|
n/a | 1,259.671 | 21.09 | 17.97 | 0.25 | 0.24 | 4.65 | |
|
99 Cents Only Stores
|
|
n/a | 807.044 | 51.68 | 51.62 | 0.81 | 0.69 | 1.63 | |
|
Stereotaxis, Inc.
|
|
n/a | 341.699 | n/a | -6.71 | 29.27 | 11.59 | 5.23 | |
|
1-800 CONTACTS, INC.
|
|
n/a | 200.198 | n/a | 95.40 | 0.82 | n/a | 22.21 | |
|
Barrier Therapeutics, Inc.
|
|
n/a | 132.043 | n/a | -2.67 | 55.95 | 16.37 | 2.06 | |
|
Discovery Laboratories
|
|
n/a | 106.487 | n/a | -2.21 | 1,451.21 | 1,052.63 | 4.87 | |
|
GTC Biotherapeutics, Inc.
|
|
n/a | 81.045 | n/a | -2.87 | 16.11 | 10.42 | 3.98 | |
|
Osteotech, Inc.
|
|
n/a | 65.383 | n/a | 37.20 | 0.69 | 0.64 | 0.92 | |
|
Boston Life Sciences, Inc.
|
|
n/a | 53.153 | n/a | n/a | n/a | n/a | 11.74 | |
| Target | |||||||||
|
McKesson Corporation
|
|
16.00% | 15,589.221 | 20.81 | 19.55 | 0.17 | 0.16 | 3.92 | |
|
AmerisourceBergen Corp.
|
|
13.00% | 8,802.317 | 24.36 | 20.75 | 0.15 | 0.15 | 5.31 | |
|
Walgreen Company
|
|
10.00% | 49,039.495 | 29.50 | 29.03 | 1.07 | 1.06 | 5.01 | |
|
Cardinal Health, Inc.
|
|
9.00% | 28,155.662 | 28.60 | 18.49 | 0.35 | 0.32 | 8.05 | |
|
Government - United States
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
- Defined by the Company
- Defined by Others
Key Partners
| Name | Dir | Percent | Market Cap. | P/E Ratio (TTM) | Fwd P/E | P/R Ratio (TTM) | Fwd P/Rev | Price To Tang. Book Value | |
|---|---|---|---|---|---|---|---|---|---|
| Overlap | |||||||||
|
Mylan Laboratories Inc.
|
|
n/a | 4,433.358 | 21.05 | 15.83 | 3.44 | 3.17 | 6.63 | |
|
Andrx Corporation
|
|
n/a | 1,728.521 | 184.87 | 32.64 | 1.73 | 1.59 | 2.27 | |
|
Genelabs Technologies
|
|
n/a | 21.738 | n/a | n/a | 3.18 | n/a | -27.76 | |
| Buyer | |||||||||
|
Genentech, Inc.
|
|
n/a | 86,373.982 | 52.80 | 44.02 | 11.03 | 9.68 | 13.41 | |
|
Amgen, Inc.
|
|
n/a | 78,791.131 | 29.28 | 18.23 | 5.95 | 5.53 | 47.35 | |
|
Abbott Laboratories
|
|
n/a | 74,862.543 | 24.11 | 19.57 | 3.39 | 3.36 | 44.96 | |
|
Wyeth
|
|
n/a | 63,595.794 | 16.78 | 15.21 | 3.27 | 3.18 | 6.73 | |
|
Eli Lilly & Co.
|
|
n/a | 62,205.854 | 19.81 | 17.82 | 4.13 | 4.08 | 5.21 | |
|
Bayer AG (ADR)
|
|
n/a | 37,210.919 | 19.10 | 16.63 | 1.04 | 1.15 | 6.75 | |
|
Cardinal Health, Inc.
|
|
n/a | 28,155.662 | 28.60 | 18.49 | 0.35 | 0.32 | 8.05 | |
|
Teva Pharmaceutical Industries Ltd (ADR)
|
|
n/a | 26,074.362 | 1,055.64 | 15.89 | 3.97 | 3.09 | -846.57 | |
|
McKesson Corporation
|
|
n/a | 15,589.221 | 20.81 | 19.55 | 0.17 | 0.16 | 3.92 | |
|
Quest Diagnostics Incorporated
|
|
n/a | 12,320.781 | 22.97 | 20.56 | 2.07 | 1.96 | -28.10 | |
|
Shire plc (ADR)
|
|
n/a | 8,344.273 | n/a | 29.21 | 4.93 | 4.58 | 10.15 | |
|
Pharmaceutical Product Development, Inc.
|
|
n/a | 4,539.022 | 30.01 | 28.76 | 3.93 | 3.83 | 7.13 | |
|
Mylan Laboratories Inc.
|
|
n/a | 4,433.358 | 21.05 | 15.83 | 3.44 | 3.17 | 6.63 | |
| Target | |||||||||
|
Bristol Myers Squibb Co.
|
|
n/a | 42,555.965 | 14.91 | 18.05 | 2.20 | 2.22 | 8.77 | |
|
Elan Corporation, plc (ADR)
|
|
n/a | 6,415.669 | n/a | -19.55 | 11.89 | 10.65 | -9.44 | |
|
Mylan Laboratories Inc.
|
|
n/a | 4,433.358 | 21.05 | 15.83 | 3.44 | 3.17 | 6.63 | |
|
Andrx Corporation
|
|
n/a | 1,728.521 | 184.87 | 32.64 | 1.73 | 1.59 | 2.27 | |
|
West Pharmaceutical Services Inc.
|
|
n/a | 1,239.656 | 21.06 | 20.63 | 1.48 | n/a | 5.43 | |
|
Interpharm Holdings, Inc.
|
|
n/a | 73.413 | n/a | n/a | 1.26 | n/a | 3.24 | |
|
Novadel Pharma Inc
|
|
n/a | 63.660 | n/a | n/a | 32.75 | n/a | 5.13 | |
|
Genelabs Technologies
|
|
n/a | 21.738 | n/a | n/a | 3.18 | n/a | -27.76 | |
|
Cipla Ltd.
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
- Defined by the Company
- Defined by Others
Financials
| Buyer | Target | Combined Entity | |
|---|---|---|---|
| Income Statement | |||
| Operating Items | |||
| Revenue | 51,275.0 | 1,746.7 | 53,021.7 |
|
Other Revenue
|
0.0 | 0.0 | 0.0 |
| Total Revenue | 51,275.0 | 1,746.7 | 53,021.7 |
|
Cost of Revenue
|
14,364.0 | 999.9 | 15,363.9 |
|
SG&A Expense
|
17,086.0 | 266.7 | 17,352.7 |
|
Depreciation & Amortization
|
0.0 | 164.4 | 164.4 |
|
Research & Development
|
6,838.0 | 125.9 | 6,963.9 |
|
Interest Expense
|
-647.0 | 0.0 | -647.0 |
|
Other Operating Expense
|
-909.0 | 0.0 | -909.0 |
|
Unusual Expense (Income)
|
133.0 | 92.1 | 225.1 |
| Total Expenses | 36,865.0 | 1,649.0 | 38,514.0 |
|
Operating Income
|
14,410.0 | 97.7 | 14,507.7 |
| Non Operating Items | |||
|
Interest Expense (Inc.), Net Non-Oprtng
|
0.0 | 9.1 | 9.1 |
|
Gain/Loss On Sale Of Assets
|
0.0 | 3.3 | 3.3 |
|
Other, Net
|
0.0 | -1.1 | -1.1 |
| Income Before Taxes | 14,410.0 | 109.0 | 14,519.0 |
| Income Taxes | 3,477.0 | 40.2 | 3,517.2 |
| Income After Taxes | 10,933.0 | 68.8 | 11,001.8 |
|
Net Income - Excl. Xord. Items
|
10,933.0 | 68.8 | 11,001.8 |
|
Net Income - Incl. Xord. Items
|
10,933.0 | 68.8 | 11,001.8 |
|
Income Avail. to Common
|
10,933.0 | 68.8 | 11,001.8 |
| Share Items | |||
|
Basic Avg. Shares Outstanding
|
2,954.0 | 101.7 | 3,055.7 |
|
Basic EPS - Excl. Xord. Items
|
3.70 | 0.68 | 3.60 |
|
Basic EPS - Incl. Xord. Items
|
3.70 | 0.68 | 3.60 |
| Full Dilution Adjustment | 0.0 | 0.0 | 0.0 |
| Fully Diluted Shares Outstanding | 2,974.4 | 101.7 | 3,076.1 |
|
F.D. EPS - Excl. Xord. Items
|
3.68 | 0.68 | 3.58 |
|
F.D. EPS - Incl. Xord. Items
|
3.68 | 0.68 | 3.58 |
| Dividends Per Common Share | 1.36 | 0.00 | 1.36 |
| Balance Sheet | |||
| Assets | |||
|
Cash and Equivalents
|
14,647.0 | 600.4 | 15,247.4 |
|
ST Investments
|
78.0 | 169.0 | 247.0 |
|
Accounts Receivable
|
8,162.0 | 347.8 | 8,509.8 |
|
Inventory
|
4,313.0 | 310.4 | 4,623.4 |
|
Prepayments and Advances
|
2,223.0 | 33.4 | 2,256.4 |
|
Other Current Assets
|
2,091.0 | 110.9 | 2,202.0 |
|
Current Assets
|
31,514.0 | 1,572.1 | 33,086.1 |
|
PPE
|
20,965.0 | 0.0 | 20,965.0 |
|
Accum D&A
|
-9,678.0 | 0.0 | -9,678.0 |
|
PPE, Net
|
11,287.0 | 449.4 | 11,736.4 |
| Goodwill & Intangibles | 13,274.0 | 1,080.6 | 14,354.6 |
| Long Term Investments | 21.0 | 63.3 | 84.3 |
| Other Assets | 0.0 | 0.0 | 0.0 |
|
Other LT Assets
|
4,894.0 | 25.5 | 4,919.6 |
| Total Assets | 60,990.0 | 3,190.9 | 64,180.9 |
| Liabilities | |||
| Accounts Payable | 4,089.0 | 0.0 | 4,089.0 |
| Payable/Accrued | 0.0 | 298.6 | 298.6 |
| Accrued Expenses | 6,219.0 | 0.0 | 6,219.0 |
|
ST Debt
|
654.0 | 0.0 | 654.0 |
|
Curr Port of LTD & Cap Lease Oblg
|
0.0 | 10.4 | 10.4 |
| Other (Current) Liabilities | 1,227.0 | 72.1 | 1,299.1 |
|
Current Liab.
|
12,189.0 | 381.1 | 12,570.1 |
|
LT Debt
|
1,981.0 | 574.0 | 2,555.0 |
|
Total LT Debt
|
1,981.0 | 574.0 | 2,555.0 |
| Deferred Taxes | 322.0 | 88.8 | 410.8 |
|
Other LT Liab.
|
5,756.0 | 15.7 | 5,771.7 |
|
Total Liabilities
|
20,248.0 | 1,059.6 | 21,307.6 |
| Shareholders Equity | |||
| Common Stock | 3,120.0 | 0.4 | 3,120.4 |
| Additional Paid in Capital | 0.0 | 929.0 | 929.0 |
| Retained Earnings | 46,530.0 | 1,494.7 | 48,024.7 |
| Treasure Stock | -8,358.0 | -300.0 | -8,658.0 |
| Other Equity | -550.0 | 7.2 | -542.8 |
|
Total Equity
|
40,742.0 | 2,131.3 | 42,873.3 |
|
Total Liab. & Equity
|
60,990.0 | 3,190.9 | 64,180.9 |
|
Shares Outstanding
|
2,934.0 | 102.2 | 3,036.1 |
| Cash Flow | |||
| Operating Cash Flow | |||
| CF Net Income | 11,109.0 | 68.8 | 11,177.8 |
| CF Depreciation | 2,097.0 | 47.7 | 2,144.7 |
| CF Amortization | 0.0 | 164.4 | 164.4 |
| CF Deferred Taxes | -462.0 | -55.1 | -517.1 |
| Other Non-Cash Items | 183.0 | 123.3 | 306.3 |
| Change in Working Capital | 131.0 | -6.4 | 124.6 |
| Total Cash From Operating Activities | 13,058.0 | 342.8 | 13,400.8 |
| Investing Cash Flow (not calculated) | |||
| Capital Expenditures | -2,792.0 | -61.8 | -2,853.8 |
| Other Investing Cash Flows | -689.0 | -56.2 | -745.2 |
| Total Cash From Investing Activities | -3,481.0 | -117.9 | -3,598.9 |
| Financing Cash Flow (not calculated) | |||
| Dividends Paid | -4,053.0 | 0.0 | -4,053.0 |
| Purchase Or Sale of Stock | -3,124.0 | -92.9 | -3,216.9 |
| Purchase and Retirement of Debt | 37.0 | -18.8 | 18.2 |
| Other Financing Cash Flow | 0.0 | -1.5 | -1.5 |
| Total Cash From Financing Activities | -7,138.0 | -113.2 | -7,251.2 |
| Exchange Rate Effects | 52.0 | 0.0 | 52.0 |
| Net Change in Cash | 2,491.0 | 111.7 | 2,602.7 |
| Cash Taxes Paid | 3,429.0 | 112.2 | 3,541.2 |
| Cash Interest Paid | 151.0 | 12.4 | 163.4 |